rfhg_19638.1

Basic information about the TSS

---

TSS ID: rfhg_19638.1 Species: human Chr: chr1		Start: 212285573 End: 212285592 Strand: +
Source datasets	FANTOM5
Protocol	CAGE
TSS cluster detected*	1

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	PLS,CTCF-bound (EH38D2273067,EH38E1420132)
Category:	PLS

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: L42373:-36 GeneID: 5525 HGNC/MGI_ID: HGNC:9309 UniProt_ID: Nearer transcript ids and distances: AK312530:-133 ENST00000261461.7:-163 NM_006243.4:-163 BC110883:236 BC022474:362 view more...

Gene_name: protein phosphatase 2 regulatory subunit B'alpha Gene_symbol: PPP2R5A Gene_synonyms: B56A B56alpha PR61A Gene_source: HGNC:9309

TATA-Box annotation

---

Distance to TSS:	172
Nearest PromoterID:	NM_006243
Entrez ID:	5525
Nearest Unigene:	Hs.744012
Nearest Refseq:	NM_006243
Nearest Ensembl:	ENSG00000066027
Gene Name:	protein phosphatase 2 regulatory subunit B'alpha
Gene Alias:	B56A|B56alpha|PR61A
Gene Type:	protein-coding
CpG%:	0.105263
GC%:	0.700000
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@PPP2R5A p2@PPP2R5A p3@PPP2R5A p4@PPP2R5A p5@PPP2R5A
Sample		p1@PPP2R5A	p2@PPP2R5A	p3@PPP2R5A	p4@PPP2R5A	p5@PPP2R5A
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	21.23	6.43	2.92	0.78	0.78
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	22.05	7.08	2.02	0.61	0.81
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	16.98	6.37	1.35	0.58	0.58
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	15.80	6.24	1.87	0.21	0.62
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	19.12	4.95	1.35	0.90	0.22
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	20.16	4.07	1.74	0.58	0.39
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	23.97	5.45	3.27	0.44	0.44
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	20.59	3.39	1.70	0.48	0.73
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	20.52	2.99	2.14	0.64	0.43
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	35.94	2.32	4.06	0.58	2.32
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	33.15	2.83	4.45	0.81	1.21
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	23.99	1.63	3.66	0.41	1.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	17.73	8.06	0.81	1.45	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	13.08	4.36	0.75	1.65	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	14.05	5.05	1.32	1.54	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	12.57	3.77	1.26	0.75	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	13.76	4.37	1.09	0.66	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	14.34	3.37	0.42	0.84	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	13.86	3.73	0.53	0.00	0.53
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	13.09	6.62	1.05	0.75	0.15
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	13.63	4.41	1.20	1.07	0.13
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	13.98	5.01	0.52	0.86	0.17
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	10.60	4.65	1.16	0.65	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	13.10	3.15	0.73	0.73	0.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	6.71	3.61	0.52	0.77	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	11.08	2.85	0.95	1.27	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	12.64	3.85	1.10	1.10	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	11.32	4.24	1.65	1.41	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	11.63	2.58	0.97	0.97	0.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	11.04	4.16	0.72	0.72	0.18
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	6.70	2.51	0.63	0.84	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	5.86	2.15	0.98	0.78	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	6.33	3.80	1.90	0.42	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	10.56	3.13	1.15	0.33	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	5.80	2.62	0.56	0.37	0.19
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	6.13	1.92	0.77	0.38	0.38
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	6.54	4.70	0.82	0.82	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	6.04	3.02	1.21	0.20	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	6.21	4.05	0.54	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	5.76	3.60	1.44	0.24	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	5.65	4.23	0.94	0.47	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	4.98	3.22	1.46	0.44	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	4.64	1.90	1.48	0.63	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	3.50	3.32	0.52	0.35	0.17
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	4.22	3.41	1.20	0.20	0.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	4.42	2.09	1.40	0.23	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	4.80	2.64	0.96	0.24	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	3.58	4.77	0.30	0.30	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	4.31	3.11	0.48	0.24	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	4.04	2.83	1.62	0.40	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	4.51	1.23	0.82	0.41	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	3.34	2.00	1.11	0.22	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	5.68	1.42	0.71	0.00	0.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	2.32	0.99	0.99	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	5.03	1.68	0.84	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	5.05	1.84	0.46	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	1.94	1.30	1.30	0.32	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	2.25	0.96	1.61	0.32	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	4.40	1.89	0.94	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	3.53	1.41	0.00	0.71	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	2.80	0.56	1.12	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	5.57	1.59	0.80	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	2.38	2.04	0.34	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	1.30	0.97	0.97	0.00	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	3.90	0.71	0.35	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	32.33	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	7.90	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	3.41	3.41	0.98	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	3.47	3.47	0.50	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	6.57	2.81	0.47	0.00	0.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	5.30	4.31	1.99	0.66	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	3.09	2.17	0.31	0.31	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	4.59	3.36	0.61	0.61	0.00
Adipocyte - breast, donor1	11376-118A8	14.73	3.64	1.27	0.32	0.16
Adipocyte - breast, donor2	11327-117E4	30.64	5.13	1.76	0.80	0.64
Adipocyte - omental, donor1	11473-119C6	20.10	2.54	1.78	0.13	0.13
Adipocyte - omental, donor2	11474-119C7	13.45	2.99	0.75	0.00	0.75
Adipocyte - omental, donor3	11475-119C8	10.38	1.34	0.67	0.33	0.00
Adipocyte - perirenal, donor1	11476-119C9	7.66	0.00	0.00	0.00	0.00
Adipocyte - subcutaneous, donor1	11259-116F8	17.59	0.00	3.30	1.10	1.10
Adipocyte - subcutaneous, donor2	11336-117F4	12.19	7.23	0.90	0.90	0.00
Adipocyte - subcutaneous, donor3	11408-118E4	31.97	6.26	2.78	1.56	1.39
Adipocyte differentiation, day04, donor1	13019-139D4	18.97	7.24	3.13	1.17	0.59
Adipocyte differentiation, day04, donor2	13022-139D7	9.27	3.09	0.26	0.51	0.26
Adipocyte differentiation, day04, donor3	13025-139E1	18.12	4.74	0.56	1.39	0.56
Adipocyte differentiation, day04, donor4	13028-139E4	49.38	9.40	3.53	2.35	2.35
Adipocyte differentiation, day08, donor1	13020-139D5	94.11	13.59	3.54	2.25	1.05
Adipocyte differentiation, day08, donor2	13023-139D8	39.05	10.01	1.94	1.61	1.94
Adipocyte differentiation, day08, donor3	13026-139E2	50.12	8.53	2.13	0.53	1.60
Adipocyte differentiation, day08, donor4	13029-139E5	86.80	6.68	1.67	1.11	1.11
Adipocyte differentiation, day12, donor1	13021-139D6	74.03	8.73	5.82	1.66	2.50
Adipocyte differentiation, day12, donor2	13024-139D9	53.00	5.02	4.02	1.00	1.00
Adipocyte differentiation, day12, donor3	13027-139E3	68.72	8.84	5.56	1.64	0.33
Adipocyte differentiation, day12, donor4	13030-139E6	68.51	10.35	3.04	2.13	2.44
Alveolar Epithelial Cells, donor1	11510-119G7	5.75	1.99	2.21	0.22	0.22
Alveolar Epithelial Cells, donor2	11590-120G6	2.15	0.72	0.00	0.00	0.00
Alveolar Epithelial Cells, donor3	11671-122G6	0.00	0.00	0.00	0.00	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	10.61	1.26	0.90	0.18	0.00
Amniotic Epithelial Cells, donor2	11613-122A2	1.67	0.00	0.00	0.00	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	4.52	0.62	0.21	0.00	0.00
Anulus Pulposus Cell, donor1	11248-116E6	10.64	3.43	1.03	0.34	0.00
Anulus Pulposus Cell, donor2	11463-119B5	10.29	2.94	0.98	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	5.39	1.35	0.45	0.45	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	3.91	2.17	0.87	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	2.14	0.00	0.00	2.14	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	5.68	2.09	1.20	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	13.91	0.00	1.26	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	1.32	0.66	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	4.55	1.30	0.32	0.65	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	2.91	0.97	0.97	0.49	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	4.75	0.59	0.59	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	4.52	1.88	0.38	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	2.90	2.90	0.73	0.73	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	1.25	1.25	1.25	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	3.46	1.15	0.66	0.33	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	6.82	0.00	1.36	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	3.62	0.60	0.00	0.15	0.15
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	6.97	2.14	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	3.78	0.57	1.32	0.19	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	4.28	0.80	0.27	0.27	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	2.93	0.98	1.95	0.98	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	3.65	0.83	0.66	0.17	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	7.20	0.00	2.40	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	3.54	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	3.95	0.86	0.34	0.00	0.17
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	4.19	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	5.83	0.97	0.97	0.97	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	2.66	0.38	0.38	1.14	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	6.06	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	5.70	0.57	0.57	0.57	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	3.21	0.86	0.86	0.64	0.21
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	5.94	0.52	1.03	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	6.57	0.47	0.94	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	6.43	0.64	0.64	0.32	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	3.57	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	4.68	0.58	1.17	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	3.91	1.20	1.51	0.30	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	2.38	0.00	1.19	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	4.58	0.51	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	3.82	0.76	0.76	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	3.18	0.64	1.27	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	5.18	0.86	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	3.60	2.12	0.00	0.21	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	3.77	0.58	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	7.56	1.89	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	3.39	0.85	0.85	0.17	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	4.23	2.11	2.11	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	3.00	1.07	0.43	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	4.21	0.00	0.60	0.00	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	3.64	0.00	1.46	0.00	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	3.91	1.61	0.92	0.00	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	2.55	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	1.78	0.76	0.25	0.25	0.25
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	3.51	1.86	1.65	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	3.98	0.61	0.31	0.00	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	1.91	0.48	0.00	0.48	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	4.21	0.22	0.22	0.00	0.22
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	1.53	0.00	0.00	1.53	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	1.66	0.55	1.66	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	3.18	0.53	0.26	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	5.09	0.00	0.36	0.00	0.00
Astrocyte - cerebellum, donor1	11500-119F6	8.11	0.61	0.37	0.25	0.00
Astrocyte - cerebellum, donor2	11580-120F5	5.82	0.86	0.34	0.34	0.00
Astrocyte - cerebellum, donor3	11661-122F5	2.94	0.84	0.00	0.21	0.00
Astrocyte - cerebral cortex, donor1	11235-116D2	6.62	3.14	0.00	1.05	0.35
Astrocyte - cerebral cortex, donor2	11316-117D2	8.09	3.56	0.81	0.65	0.32
Astrocyte - cerebral cortex, donor3	11392-118C6	6.41	3.73	0.00	0.30	0.00
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	20.76	19.04	1.95	1.15	0.23
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	18.79	18.42	3.38	1.00	0.13
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	21.28	15.93	3.53	1.02	0.23
Basophils, donor1	12241-129G9	59.89	15.69	11.51	0.78	1.31
Basophils, donor2	12242-129H1	50.51	14.43	21.29	1.44	1.44
Basophils, donor3	12243-129H2	29.11	10.14	13.08	2.94	0.73
Bronchial Epithelial Cell, donor1	11511-119G8	8.41	1.51	0.86	0.43	0.00
Bronchial Epithelial Cell, donor2	11591-120G7	1.83	2.29	0.46	0.00	0.00
Bronchial Epithelial Cell, donor3	11672-122G7	7.17	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	4.39	0.00	0.63	0.00	0.63
Bronchial Epithelial Cell, donor5	11457-119A8	3.74	0.83	0.83	0.42	0.21
Bronchial Epithelial Cell, donor6	11461-119B3	5.76	2.53	2.30	0.46	0.23
Bronchial Epithelial Cell, donor7	11769-123I5	14.22	2.70	1.44	0.54	0.18
Burkitt's lymphoma cell line:DAUDI	10422-106C8	30.50	3.71	4.53	0.62	0.52
Burkitt's lymphoma cell line:RAJI	10476-106I8	18.63	8.85	3.49	1.16	0.47
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	21.42	9.27	11.19	1.28	0.32
CD133+ stem cells - cord blood derived, pool1	12223-129E9	62.05	10.34	10.34	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	40.58	12.40	12.96	1.69	0.56
CD14+ Monocytes, donor2	11305-117B9	40.28	7.98	12.06	0.93	0.74
CD14+ Monocytes, donor3	11381-118B4	39.96	9.44	10.54	1.76	1.10
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	53.50	9.34	6.79	1.13	0.28
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	41.32	10.24	4.93	1.14	0.00
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	45.69	10.19	7.89	1.97	0.33
CD14+ monocytes - mock treated, donor1	11863-125A9	33.97	3.18	4.05	0.72	0.00
CD14+ monocytes - mock treated, donor2	11873-125C1	19.61	5.73	0.60	0.60	0.30
CD14+ monocytes - mock treated, donor3	11883-125D2	27.95	4.26	3.55	1.18	0.47
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	21.26	2.51	3.01	0.50	0.17
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	16.56	5.24	2.48	1.10	0.28
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	25.29	6.45	3.72	0.25	0.25
CD14+ monocytes - treated with BCG, donor1	11860-125A6	14.88	1.96	2.55	0.20	0.20
CD14+ monocytes - treated with BCG, donor2	11870-125B7	10.86	3.38	1.07	0.18	0.00
CD14+ monocytes - treated with BCG, donor3	11880-125C8	16.54	2.61	1.96	0.44	0.44
CD14+ monocytes - treated with Candida, donor1	11868-125B5	17.79	2.34	1.40	0.23	0.00
CD14+ monocytes - treated with Candida, donor2	11878-125C6	22.71	2.11	2.64	0.00	0.00
CD14+ monocytes - treated with Candida, donor3	11888-125D7	23.30	0.00	1.11	0.00	0.00
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	21.12	1.64	2.38	0.15	0.30
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	12.77	3.39	2.99	0.00	0.60
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	17.91	2.29	4.16	0.21	0.21
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	15.33	1.14	2.52	0.00	0.23
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	14.25	1.81	3.85	0.00	0.45
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	14.84	0.87	3.06	0.00	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	19.10	1.61	1.61	0.27	0.27
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	14.13	2.44	3.14	0.70	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	25.25	2.95	3.37	0.00	0.00
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	10.84	1.65	3.12	0.37	0.00
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	16.20	4.58	1.76	0.00	0.00
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	14.92	1.75	1.32	0.00	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	15.52	4.01	3.66	0.52	0.52
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	12.64	4.46	1.86	0.74	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	18.54	2.59	2.80	0.65	0.43
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	13.92	2.46	3.28	0.00	1.23
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	17.38	1.62	2.32	0.00	0.46
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	11.14	1.62	1.62	0.46	0.23
CD14+CD16+ Monocytes, donor1	11789-124B7	63.86	8.28	8.06	0.22	0.00
CD14+CD16+ Monocytes, donor2	11801-124D1	77.85	8.32	9.93	1.39	1.62
CD14+CD16+ Monocytes, donor3	11912-125G4	55.45	8.66	8.01	0.65	0.87
CD14+CD16- Monocytes, donor1	11788-124B6	97.48	10.74	8.56	0.78	0.47
CD14+CD16- Monocytes, donor2	11799-124C8	81.21	8.21	7.86	0.52	0.17
CD14+CD16- Monocytes, donor3	11910-125G2	105.02	10.93	7.80	2.45	0.89
CD14-CD16+ Monocytes, donor1	11790-124B8	84.46	9.19	8.93	0.77	1.02
CD14-CD16+ Monocytes, donor2	11800-124C9	93.97	10.10	9.00	1.32	1.76
CD14-CD16+ Monocytes, donor3	11911-125G3	86.53	9.47	8.42	1.26	1.26
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	34.55	16.26	16.26	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	42.71	18.31	14.24	3.39	0.68
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	49.71	25.89	15.53	0.00	0.00
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	75.16	28.78	12.79	1.07	0.53
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	44.49	18.76	13.40	0.54	0.54
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	44.22	14.74	15.44	0.70	0.00
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	54.12	22.75	8.63	1.57	1.57
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	58.00	26.37	21.09	2.64	3.95
CD19+ B Cells, donor1	11544-120B5	41.10	13.15	27.94	2.47	1.64
CD19+ B Cells, donor2	11624-122B4	28.29	9.43	14.51	1.45	0.00
CD19+ B Cells, donor3	11705-123B4	32.81	14.64	21.71	1.01	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	35.56	2.42	2.42	0.00	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	27.17	1.20	2.40	0.40	0.00
CD34+ Progenitors, donor1	11545-120B6	8.03	5.02	3.01	1.00	0.00
CD34+ Progenitors, donor2	11625-122B5	33.15	7.30	11.80	0.00	0.56
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	27.43	5.64	7.89	1.50	0.75
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	27.28	6.99	4.96	0.23	0.45
CD4+ T Cells, donor1	11225-116C1	86.76	27.85	62.13	0.36	0.36
CD4+ T Cells, donor2	11306-117C1	80.83	23.27	51.44	0.00	1.22
CD4+ T Cells, donor3	11382-118B5	59.47	18.91	34.77	1.83	0.91
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	87.55	17.10	16.85	2.30	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	72.99	15.27	17.74	0.45	0.45
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	87.96	18.40	14.95	0.86	0.29
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	65.42	24.18	30.34	1.42	0.47
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	56.89	21.07	33.01	2.11	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	62.63	19.78	26.37	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	58.53	17.63	14.16	0.29	0.14
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	51.01	11.69	12.54	1.02	0.17
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	42.72	11.77	12.25	0.81	0.16
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	51.55	20.62	29.14	0.90	0.45
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	56.60	35.64	25.16	1.40	1.05
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	62.04	29.48	20.68	0.88	1.32
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	73.37	24.88	8.85	2.53	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	41.14	18.91	8.31	0.62	0.42
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	38.42	11.03	9.02	1.67	0.33
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	61.73	15.23	29.10	0.27	0.27
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	76.10	18.76	38.59	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	39.45	7.17	32.28	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	94.75	24.85	13.72	1.30	0.74
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	61.30	13.43	13.86	1.30	0.22
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	71.03	21.65	16.60	1.26	0.42
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	65.73	14.66	31.35	1.01	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	54.59	18.20	28.16	2.60	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	47.07	21.35	23.53	1.74	0.87
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	58.39	28.21	33.16	0.99	0.99
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	38.77	24.00	27.70	1.85	0.92
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	46.06	16.75	33.50	1.40	2.79
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	82.25	20.49	20.49	1.38	0.28
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	69.45	27.73	29.69	1.23	1.47
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	78.54	27.72	18.48	1.54	3.08
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	60.16	26.14	22.92	0.72	0.36
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	60.94	33.24	19.39	5.54	0.00
CD8+ T Cells, donor1	11226-116C2	74.97	37.00	46.82	2.62	2.62
CD8+ T Cells, donor2	11307-117C2	70.96	33.41	35.67	1.50	1.88
CD8+ T Cells, donor3	11383-118B6	68.68	27.52	40.65	1.51	2.02
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	4.59	9.86	2.98	0.92	0.00
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	5.75	9.83	1.44	0.48	0.00
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	4.92	7.93	2.19	0.27	0.00
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	3.90	3.90	3.60	0.00	0.30
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	8.16	11.76	3.12	0.24	0.24
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	4.78	8.87	4.78	0.91	0.00
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	5.21	8.91	2.61	0.65	0.00
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	9.48	7.37	3.42	0.26	0.00
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	11.02	10.32	3.52	0.23	0.00
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	7.55	9.06	1.51	0.30	0.30
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	8.13	10.46	2.32	0.58	0.00
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	7.46	11.19	2.93	0.53	0.00
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	11.82	13.57	3.50	0.44	1.31
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	10.47	9.11	5.92	0.91	0.46
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	11.19	14.92	2.24	0.75	1.49
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	2.52	9.72	6.48	1.08	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	6.04	10.07	1.73	0.29	0.29
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	3.54	9.66	3.54	0.71	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	5.07	11.73	1.27	1.27	0.32
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	7.07	13.53	2.77	0.62	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	6.41	14.11	3.21	0.32	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	6.12	11.09	2.29	0.00	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	8.28	13.01	3.55	1.18	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	8.32	12.10	5.29	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	18.47	13.65	4.82	3.21	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	18.88	14.69	3.50	0.70	2.10
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	20.04	18.03	3.01	4.01	1.00
Cardiac Myocyte, donor1	11525-119I4	12.79	0.00	0.00	1.83	0.00
Cardiac Myocyte, donor2	11605-120I3	10.38	2.96	0.49	0.00	0.00
Cardiac Myocyte, donor3	11686-122I3	13.05	2.42	1.37	0.11	0.11
Chondrocyte - de diff, donor1	11261-116G1	7.97	1.04	2.43	0.69	0.00
Chondrocyte - de diff, donor2	11338-117F6	6.04	1.42	1.07	0.00	0.00
Chondrocyte - de diff, donor3	11410-118E6	8.65	2.39	1.48	0.23	0.46
Chondrocyte - re diff, donor2	11339-117F7	2.69	4.48	1.79	0.00	0.00
Chondrocyte - re diff, donor3	11411-118E7	4.85	4.04	0.81	0.00	0.40
Ciliary Epithelial Cells, donor1	11242-116D9	10.10	2.41	0.80	0.34	0.23
Ciliary Epithelial Cells, donor2	11323-117D9	5.13	2.99	0.64	0.64	0.00
Ciliary Epithelial Cells, donor3	11399-118D4	6.81	4.60	1.59	0.53	0.09
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	44.47	6.69	5.59	1.01	0.46
Corneal Epithelial Cells, donor1	11526-119I5	6.15	2.63	0.44	0.22	0.00
Corneal Epithelial Cells, donor2	11606-120I4	5.69	1.14	0.00	1.14	0.00
Corneal Epithelial Cells, donor3	11687-122I4	5.37	1.53	0.26	0.51	0.51
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	4.62	9.25	4.46	1.32	0.17
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	7.25	12.30	3.78	0.63	0.32
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	10.35	6.90	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	5.40	10.15	3.89	0.32	0.43
Dendritic Cells - plasmacytoid, donor1	11228-116C4	34.16	8.54	11.96	0.34	0.00
Dendritic Cells - plasmacytoid, donor2	11309-117C4	18.28	11.75	8.49	0.00	0.00
Dendritic Cells - plasmacytoid, donor3	11385-118B8	36.30	11.13	24.68	0.00	0.00
Endothelial Cells - Aortic, donor0	11207-116A1	11.34	3.84	2.00	0.17	0.00
Endothelial Cells - Aortic, donor1	11263-116G3	2.93	0.59	1.17	1.17	0.00
Endothelial Cells - Aortic, donor2	11340-117F8	12.44	1.13	1.13	0.85	0.00
Endothelial Cells - Aortic, donor3	11412-118E8	8.26	0.79	0.39	0.00	0.00
Endothelial Cells - Artery, donor1	11264-116G4	4.94	0.87	0.29	0.58	0.00
Endothelial Cells - Artery, donor2	11341-117F9	8.23	0.71	0.94	0.47	0.24
Endothelial Cells - Artery, donor3	11413-118E9	5.79	0.53	1.23	0.35	0.00
Endothelial Cells - Lymphatic, donor1	11236-116D3	41.67	5.98	2.44	0.66	0.22
Endothelial Cells - Lymphatic, donor2	11317-117D3	35.29	4.26	4.26	0.91	0.30
Endothelial Cells - Lymphatic, donor3	11393-118C7	49.05	5.07	1.97	1.13	0.85
Endothelial Cells - Microvascular, donor1	11265-116G5	13.07	0.30	0.89	0.00	0.00
Endothelial Cells - Microvascular, donor2	11342-117G1	7.81	0.52	0.00	0.00	0.00
Endothelial Cells - Microvascular, donor3	11414-118F1	16.02	1.70	0.99	0.85	0.14
Endothelial Cells - Thoracic, donor1	11266-116G6	32.41	5.20	2.40	0.80	0.40
Endothelial Cells - Thoracic, donor2	11343-117G2	5.77	2.10	0.52	0.00	0.00
Endothelial Cells - Umbilical vein, donor1	11243-116E1	68.21	8.45	3.98	0.87	0.37
Endothelial Cells - Umbilical vein, donor2	11324-117E1	35.63	4.35	3.91	0.43	0.43
Endothelial Cells - Umbilical vein, donor3	11400-118D5	31.88	4.64	3.42	0.85	0.24
Endothelial Cells - Vein, donor1	11267-116G7	9.10	2.28	2.28	0.00	0.00
Endothelial Cells - Vein, donor2	11344-117G3	10.48	0.00	0.70	0.00	0.00
Endothelial Cells - Vein, donor3	11416-118F3	19.00	3.77	1.88	0.94	0.47
Eosinophils, donor1	12244-129H3	60.99	30.49	30.49	0.00	0.00
Eosinophils, donor2	12245-129H4	173.28	13.20	31.35	1.65	0.00
Eosinophils, donor3	12246-129H5	171.21	14.27	28.53	3.57	3.57
Esophageal Epithelial Cells, donor1	11507-119G4	4.64	2.44	0.73	0.73	0.73
Esophageal Epithelial Cells, donor2	11587-120G3	4.16	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	48.81	0.00	0.00	16.27	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	10.26	1.64	0.00	1.23	0.00
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	3.50	0.88	0.66	0.11	0.11
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	9.53	3.25	0.54	0.54	0.22
Fibroblast - Aortic Adventitial, donor1	11245-116E3	9.94	2.91	1.09	0.36	0.00
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	8.46	0.68	0.27	0.41	0.14
Fibroblast - Aortic Adventitial, donor2	11326-117E3	6.12	2.64	0.74	0.32	0.00
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	10.54	2.37	0.53	0.26	0.26
Fibroblast - Aortic Adventitial, donor3	11401-118D6	9.63	5.98	1.33	0.66	0.33
Fibroblast - Cardiac, donor1	11268-116G8	6.35	0.91	0.00	0.00	0.00
Fibroblast - Cardiac, donor2	11345-117G4	5.31	3.79	0.00	0.00	0.76
Fibroblast - Cardiac, donor3	11417-118F4	4.26	0.95	0.47	0.00	0.00
Fibroblast - Cardiac, donor4	11452-119A3	11.82	4.85	2.42	1.82	0.00
Fibroblast - Cardiac, donor5	11456-119A7	7.11	1.52	1.14	0.25	0.00
Fibroblast - Cardiac, donor6	11460-119B2	6.22	0.91	1.06	0.45	0.00
Fibroblast - Choroid Plexus, donor1	11492-119E7	15.01	3.35	0.67	0.54	0.27
Fibroblast - Choroid Plexus, donor2	11572-120E6	9.06	1.73	0.43	0.43	0.43
Fibroblast - Choroid Plexus, donor3	11653-122E6	2.93	1.46	0.00	0.00	0.00
Fibroblast - Conjunctival, donor1	11531-120A1	5.77	2.54	0.92	1.38	0.00
Fibroblast - Conjunctival, donor3	11692-122I9	20.18	2.04	1.87	1.19	0.34
Fibroblast - Dermal, donor1	11269-116G9	4.23	2.82	2.35	0.47	0.00
Fibroblast - Dermal, donor2	11346-117G5	5.66	3.30	3.77	0.47	0.00
Fibroblast - Dermal, donor3	11418-118F5	7.25	7.62	1.57	0.73	0.00
Fibroblast - Dermal, donor4	11450-119A1	11.64	5.20	0.79	0.90	0.00
Fibroblast - Dermal, donor5	11454-119A5	13.08	3.49	0.87	0.52	0.52
Fibroblast - Dermal, donor6	11458-119A9	9.42	4.39	1.95	1.30	0.32
Fibroblast - Gingival, donor1	11237-116D4	12.29	2.29	2.71	0.21	0.00
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	8.38	6.81	1.57	0.52	0.26
Fibroblast - Gingival, donor2	11318-117D4	11.47	2.77	1.19	1.05	0.26
Fibroblast - Gingival, donor3	11394-118C8	11.12	3.48	2.22	1.16	0.48
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	14.54	6.23	7.27	2.08	3.12
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	12.33	7.75	1.76	1.59	1.41
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	12.00	4.52	2.81	1.25	0.62
Fibroblast - Gingival, donor6 (control)	11922-125H5	10.68	3.79	2.70	0.54	0.14
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	20.47	7.06	3.53	2.82	0.71
Fibroblast - Gingival, donor7 (control)	11924-125H7	14.33	4.53	2.19	1.75	0.15
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	11.32	1.91	2.18	0.14	0.55
Fibroblast - Gingival, donor8 (control)	11926-125H9	8.45	4.28	2.85	2.08	0.77
Fibroblast - Gingival, donor9 (control)	11927-125I1	27.29	6.75	2.79	2.79	0.73
Fibroblast - Lung, donor1	11270-116H1	4.08	1.36	2.72	0.00	0.00
Fibroblast - Lung, donor2	11347-117G6	13.43	5.97	0.00	1.49	0.00
Fibroblast - Lung, donor3	11419-118F6	6.75	5.06	0.63	0.00	0.21
Fibroblast - Lymphatic, donor1	11506-119G3	9.16	4.17	0.83	0.00	0.00
Fibroblast - Lymphatic, donor2	11586-120G2	5.59	0.00	1.40	0.00	1.40
Fibroblast - Lymphatic, donor3	11667-122G2	1.96	1.12	0.28	0.00	0.00
Fibroblast - Mammary, donor1	11540-120B1	9.34	4.06	1.22	0.41	0.00
Fibroblast - Mammary, donor2	11620-122A9	3.99	0.00	0.00	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	5.96	11.91	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	12.80	3.69	1.75	1.75	0.39
Fibroblast - Periodontal Ligament, donor2	11319-117D5	10.47	5.92	1.52	1.67	0.61
Fibroblast - Periodontal Ligament, donor3	11395-118C9	11.02	3.67	2.45	1.53	1.22
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	9.54	4.96	4.58	2.29	1.14
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	8.64	3.51	1.62	1.35	0.54
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	11.25	6.03	1.97	1.51	0.70
Fibroblast - Pulmonary Artery, donor1	11250-116E8	8.51	2.10	0.99	0.44	0.11
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	5.49	1.63	1.22	0.20	0.00
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	3.34	1.34	0.67	0.67	0.00
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	6.33	4.74	1.58	1.19	0.00
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	10.72	4.17	1.19	0.60	0.40
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	12.43	3.91	2.31	0.89	0.00
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	9.46	6.70	1.97	1.18	0.39
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	7.52	2.41	1.50	1.81	0.00
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	10.90	6.15	2.27	0.65	0.32
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	12.91	3.04	0.00	0.76	0.51
Fibroblast - skin normal, donor1	11553-120C5	13.13	4.10	2.30	0.00	0.33
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	9.22	3.61	0.60	0.80	0.80
Fibroblast - skin normal, donor2	11561-120D4	9.54	4.72	2.01	0.90	0.10
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	14.51	4.84	0.91	1.51	0.00
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	12.43	5.22	1.82	1.57	0.17
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	20.00	6.33	2.39	1.03	0.00
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	10.18	1.31	0.33	0.66	0.33
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	10.44	4.37	1.49	1.49	0.32
Fibroblast - skin walker warburg, donor1	11554-120C6	9.45	3.37	1.69	0.67	0.00
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	8.00	4.08	0.47	0.78	0.00
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	44.32	0.00	44.32	0.00	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	24.40	1.74	0.87	0.87	0.00
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	12.48	2.77	4.33	1.73	0.69
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	10.67	3.12	1.04	0.78	1.56
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	12.52	3.07	2.56	1.53	1.53
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	16.84	6.12	5.36	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	26.80	4.47	3.19	0.00	1.28
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	41.93	4.28	3.71	0.00	0.29
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	15.72	5.79	1.65	0.00	0.28
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	12.10	2.28	1.83	0.46	0.23
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	24.37	6.74	2.77	0.40	0.59
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	14.01	2.91	0.26	0.26	0.53
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	9.46	1.96	1.30	0.00	0.33
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	28.30	3.98	6.19	0.88	0.44
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	29.96	2.26	2.69	0.42	0.00
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	26.11	2.59	1.97	0.49	0.37
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	23.10	2.95	1.88	0.81	0.00
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	17.59	2.11	0.74	0.25	0.25
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	19.66	3.05	1.11	0.28	0.55
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	17.28	2.03	1.22	0.41	0.00
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	23.73	1.14	1.37	0.46	0.23
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	20.43	2.87	1.99	0.37	0.37
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	28.20	5.25	1.97	0.44	0.00
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	18.62	2.95	0.89	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	18.60	1.43	1.43	0.79	0.32
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	21.67	2.46	1.12	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	16.94	1.41	0.60	0.40	0.20
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	19.85	1.87	1.53	0.34	0.17
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	27.58	3.01	2.04	0.35	0.09
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	24.14	2.91	0.94	0.94	0.83
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	27.15	3.42	1.02	0.85	1.02
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	17.70	2.66	0.66	0.55	0.77
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	23.79	2.83	1.33	0.67	0.17
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	21.44	3.06	0.82	0.82	0.41
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	16.71	1.86	1.24	0.62	0.62
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	19.25	1.50	1.04	1.04	0.23
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	14.68	2.17	0.50	1.50	0.50
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	22.04	2.20	1.10	0.66	1.10
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	23.25	2.21	0.61	1.60	1.23
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	16.21	3.24	0.32	0.32	0.81
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	26.62	4.49	1.92	0.96	0.64
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	23.40	2.56	0.95	0.76	0.76
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	13.60	3.32	0.32	0.79	0.47
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	17.64	2.13	0.61	1.52	1.22
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	18.50	2.40	0.73	1.05	1.25
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	18.88	3.07	0.66	0.66	1.54
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	20.76	1.40	1.12	1.40	1.68
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	16.11	2.31	0.46	1.48	2.04
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	17.38	1.60	0.53	1.07	0.80
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	14.84	3.37	0.92	0.61	0.92
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	13.08	2.33	0.91	1.30	1.55
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	22.23	3.25	1.08	2.17	1.08
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	17.33	1.11	0.92	1.47	1.29
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	21.93	2.85	0.22	0.88	1.10
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	26.78	3.97	0.99	0.99	1.98
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	14.38	1.85	0.40	0.53	0.66
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	17.15	2.82	1.01	1.61	0.81
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	25.16	5.34	1.02	2.54	1.27
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	35.23	6.37	4.58	0.20	0.20
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	34.05	3.85	2.31	0.62	0.00
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	32.32	4.71	3.07	0.41	0.41
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	15.65	2.50	2.19	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	17.24	3.39	1.98	0.57	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	15.22	2.77	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	24.75	2.47	4.95	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	26.30	4.64	3.09	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	32.09	1.60	8.02	0.00	3.21
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	29.56	1.74	5.22	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	29.29	2.93	1.63	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	35.00	3.71	2.06	0.41	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	33.32	10.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	27.69	3.92	0.56	0.56	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	33.99	3.60	1.31	0.98	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	22.65	3.36	0.84	1.68	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	30.85	5.41	1.27	0.00	0.32
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	27.17	4.42	1.36	1.02	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	20.88	4.18	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	29.78	5.73	0.57	0.00	0.57
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	18.94	1.18	1.48	0.30	0.30
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	22.02	5.08	1.69	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	19.05	1.66	2.07	0.83	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	18.41	2.07	2.07	0.69	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	10.54	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	18.07	4.23	1.54	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	18.58	0.98	0.33	0.65	0.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	18.06	3.34	2.01	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	30.44	1.54	0.77	0.00	0.77
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	20.20	2.74	1.37	0.00	0.34
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	29.82	2.48	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	28.78	1.89	1.89	0.94	0.47
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	22.93	1.81	3.62	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	26.96	2.54	3.05	0.51	0.51
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	23.93	3.19	0.80	0.00	0.40
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	32.56	4.44	1.48	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	29.51	3.54	0.00	0.00	1.18
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	19.84	1.75	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	35.99	1.32	0.44	0.00	0.88
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	22.04	1.70	0.85	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	32.23	1.79	0.60	0.60	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	19.90	3.40	1.46	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	1.14	4.57	0.00	1.14	0.00
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	11.64	3.74	2.08	1.66	2.08
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	5.62	3.37	0.00	0.00	0.00
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	22.20	5.39	1.90	0.95	0.00
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	12.95	3.76	1.25	2.09	0.00
Hep-2 cells mock treated, biol_rep1	11898-125E8	15.78	3.83	3.13	0.58	0.46
Hep-2 cells mock treated, biol_rep2	11899-125E9	22.62	3.54	2.70	1.35	0.51
Hep-2 cells mock treated, biol_rep3	11900-125F1	15.47	4.55	4.32	0.68	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	15.63	3.39	3.39	1.09	0.33
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	18.27	3.22	2.79	1.07	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	13.13	4.74	4.31	1.08	0.22
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	12.70	2.37	3.11	1.12	1.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	15.61	2.57	2.40	0.34	0.17
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	11.53	3.20	2.56	1.60	1.60
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	21.83	6.16	1.12	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	8.22	0.43	0.00	0.43	0.43
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	10.58	0.00	2.64	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	10.23	1.06	0.35	0.35	0.00
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	4.36	1.45	0.00	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	5.42	0.87	0.52	0.17	0.00
Hepatocyte, donor1	11523-119I2	90.80	6.05	13.32	0.00	1.21
Hepatocyte, donor2	11603-120I1	39.86	7.54	5.39	0.00	1.08
Hepatocyte, donor3	11684-122I1	82.83	11.04	9.82	0.61	0.61
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	33.29	5.22	2.61	0.00	0.00
Intestinal epithelial cells (polarized), donor1	11246-116E4	29.54	4.37	5.59	1.22	0.87
Iris Pigment Epithelial Cells, donor1	11530-119I9	4.80	0.82	0.27	0.41	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	50.94	25.47	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	46.73	13.35	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	108.33	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	35.99	9.69	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	37.54	7.51	2.50	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	23.74	11.87	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	58.95	10.25	5.13	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	41.14	18.28	4.57	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	63.35	17.87	4.87	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	40.02	6.67	1.67	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	43.57	0.00	3.63	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	71.47	18.53	1.32	1.32	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	24.39	7.76	2.22	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	78.57	10.48	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	39.05	10.08	2.52	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	15.47	9.28	1.55	1.55	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	58.54	0.00	0.00	14.63	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	49.10	8.40	0.65	0.65	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	30.59	9.66	4.83	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	47.79	0.00	23.90	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	40.74	13.85	1.63	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	36.10	13.01	2.10	0.84	0.42
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	57.49	0.00	14.37	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	32.15	16.88	1.61	1.61	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	20.31	8.31	3.69	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	30.16	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	19.83	6.14	1.89	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	27.21	3.63	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	58.97	14.74	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	48.43	8.61	4.30	1.08	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	30.49	5.08	0.00	0.00	1.27
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	32.86	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	36.35	5.10	1.28	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	25.52	7.29	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	47.41	0.00	15.80	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	29.99	7.85	1.43	1.43	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	43.14	3.32	3.32	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	41.70	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	27.47	4.63	1.85	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	36.88	7.02	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	31.43	6.29	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	38.94	6.26	0.70	0.00	0.70
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	28.77	4.43	4.43	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	29.18	19.45	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	33.13	2.62	3.49	0.00	0.87
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	45.00	6.75	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	31.36	6.97	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	23.47	4.27	1.07	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	24.94	2.77	2.77	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	54.14	11.40	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	46.94	1.84	1.84	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	30.25	6.05	3.03	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	31.04	12.42	12.42	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	32.78	1.06	1.06	0.00	0.00
Keratinocyte - epidermal, donor1	11272-116H3	7.92	2.20	1.06	0.82	0.41
Keratinocyte - epidermal, donor2	11349-117G8	1.76	2.34	1.17	0.59	0.00
Keratinocyte - epidermal, donor3	11421-118F8	9.94	4.07	1.14	2.65	0.76
Keratinocyte - oral, donor1	11251-116E9	17.71	7.83	2.84	1.25	0.45
Keratocytes, donor1	11527-119I6	3.78	1.72	0.34	0.34	0.69
Keratocytes, donor2	11607-120I5	4.69	1.17	1.17	0.00	0.00
Keratocytes, donor3	11688-122I5	5.73	1.78	2.17	0.99	0.00
Krukenberg tumor cell line:HSKTC	10687-109F3	15.39	6.59	8.79	4.40	0.00
Lens Epithelial Cells, donor1	11529-119I8	6.47	2.16	1.08	0.00	0.00
Lens Epithelial Cells, donor2	11609-120I7	8.53	2.42	1.27	0.69	0.12
Lens Epithelial Cells, donor3	11690-122I7	5.25	1.82	0.91	0.30	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	8.18	0.36	0.95	0.24	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	7.26	1.12	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	11.33	0.94	0.94	0.16	0.16
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	5.38	0.54	0.54	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	7.88	0.63	0.00	0.32	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	7.55	0.65	0.22	0.11	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	13.54	0.00	0.41	0.41	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	3.54	0.00	0.51	0.25	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	6.90	0.99	0.42	0.14	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	7.52	1.19	0.00	0.79	0.40
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	6.59	1.16	0.39	0.19	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	5.00	0.74	0.56	0.19	0.19
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	9.41	0.35	1.39	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	6.44	0.72	1.43	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	4.67	0.14	0.96	0.14	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	8.31	1.23	0.31	0.31	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	5.92	0.62	0.31	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	6.95	0.37	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	10.20	0.66	0.99	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	4.39	0.29	0.59	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	5.23	0.50	0.25	0.25	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	10.67	0.00	0.48	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	8.62	1.08	1.08	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	7.72	1.21	1.21	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	6.22	0.00	0.00	0.52	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	7.33	0.63	0.42	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	7.37	0.60	0.75	0.15	0.15
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	6.19	0.69	0.69	0.69	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	6.21	1.32	0.00	0.19	0.19
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	8.16	1.06	0.21	0.00	0.11
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	7.27	0.97	0.97	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	8.27	0.33	0.66	0.00	0.33
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	6.32	0.74	0.37	0.12	0.12
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	12.22	0.74	0.74	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	4.45	0.49	0.25	0.49	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	5.64	1.24	0.14	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	10.94	2.57	0.64	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	9.13	1.52	0.61	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	9.52	0.70	1.12	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	8.89	1.42	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	7.27	0.00	0.48	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	6.07	0.78	0.16	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	7.16	0.36	0.00	0.72	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	6.21	0.65	0.98	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	4.00	0.71	0.24	0.24	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	7.43	1.86	1.49	0.62	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	5.89	0.51	0.26	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	5.07	0.30	0.00	0.30	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	11.33	2.27	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	14.58	1.53	3.07	1.53	1.53
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	8.91	0.74	4.45	0.74	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	19.46	1.69	4.23	0.42	1.69
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	9.85	0.70	2.81	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	9.34	1.87	0.93	0.93	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	14.94	1.03	2.06	0.00	0.52
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	15.46	1.19	3.57	1.19	2.38
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	11.08	2.26	4.30	0.68	1.81
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	7.85	2.04	5.53	1.16	1.74
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	6.75	1.35	5.85	1.35	0.90
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	11.52	3.39	4.74	1.49	1.63
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	11.30	1.54	3.59	0.00	1.03
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	12.00	3.53	3.53	0.71	2.12
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	11.99	3.33	6.00	1.33	2.67
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	15.28	2.04	3.57	1.53	0.51
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	10.41	3.47	5.60	0.80	1.33
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	12.66	2.46	3.78	1.13	0.94
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	15.34	0.00	1.84	1.23	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	11.42	3.26	2.45	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	9.79	3.54	4.79	1.04	0.42
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	10.93	3.64	2.80	0.56	2.52
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	11.33	6.18	2.06	1.03	1.03
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	8.71	2.61	4.94	1.16	1.74
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	11.06	1.20	4.19	1.49	0.30
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	9.96	2.77	7.19	0.55	1.11
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	15.20	1.06	7.42	1.06	1.06
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	11.80	0.37	4.79	0.74	0.74
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	12.66	6.91	1.15	1.15	2.30
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	8.44	3.45	5.76	0.38	2.30
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	12.45	3.96	1.70	1.13	0.57
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	6.56	3.28	4.92	0.00	0.82
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	11.75	1.81	4.52	0.00	0.90
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	10.05	4.31	2.87	0.00	0.72
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	5.98	5.23	7.47	2.24	2.24
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	10.40	3.34	2.60	0.00	1.11
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	10.34	3.02	2.15	0.43	1.29
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	10.28	0.86	3.43	1.71	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	10.33	3.66	3.66	0.67	2.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	11.46	1.81	5.43	0.60	1.81
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	11.38	2.13	2.84	0.00	1.42
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	11.69	2.75	4.81	1.37	0.69
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	18.79	2.68	2.15	0.54	0.54
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	10.77	1.35	3.37	1.35	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	13.33	2.96	4.07	0.37	1.11
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	8.14	5.81	8.14	1.16	1.16
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	9.52	4.23	6.35	0.00	2.12
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	8.80	2.00	3.60	1.60	1.20
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	18.90	2.18	1.45	0.73	1.45
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	17.63	2.30	4.60	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	11.35	1.97	3.45	0.49	0.99
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	15.05	0.94	0.00	0.00	0.94
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	10.56	2.01	5.03	1.51	2.51
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	13.07	3.15	3.15	0.90	1.80
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	22.37	5.16	1.72	0.00	1.72
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	10.69	2.23	6.23	0.89	4.45
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	8.60	1.56	5.08	0.00	1.56
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	17.15	0.66	1.98	0.00	0.66
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	13.49	2.08	6.23	1.04	0.52
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	17.50	5.25	4.81	0.88	0.88
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	10.62	1.68	3.35	0.56	0.56
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	14.57	3.97	4.86	0.44	2.21
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	14.66	1.93	6.94	1.93	1.54
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	14.68	2.53	6.08	0.51	2.03
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	12.02	3.84	3.36	0.48	3.84
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	11.13	2.39	5.57	1.19	0.80
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	7.29	1.82	3.04	0.61	0.61
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	13.83	1.38	2.77	0.00	2.08
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	10.26	3.04	4.94	0.76	1.14
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	13.94	2.07	2.58	1.03	1.55
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	10.88	3.02	7.26	0.60	1.81
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	13.94	2.54	5.70	0.63	0.63
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	12.79	2.13	3.20	1.60	1.07
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	12.07	4.02	6.90	0.57	1.15
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	11.83	4.63	4.63	1.03	0.51
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	12.03	3.54	2.12	0.71	1.41
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	18.16	5.11	3.97	1.13	0.57
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	10.82	1.66	4.99	1.25	2.08
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	10.96	1.57	2.35	0.78	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	7.93	3.34	2.09	1.25	2.92
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	10.22	2.79	2.79	1.86	1.39
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	7.36	0.67	2.68	0.67	2.68
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	9.09	3.74	3.74	0.53	3.21
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	15.36	4.85	5.25	0.40	1.62
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	10.10	4.59	7.34	0.92	0.92
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	16.00	0.89	4.45	0.89	1.78
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	9.69	4.56	6.27	2.85	2.28
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	11.50	3.07	4.60	0.77	2.30
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	13.13	1.09	7.66	1.09	1.09
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	8.46	3.12	3.12	1.78	2.67
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	11.44	5.72	7.02	0.52	0.52
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	13.93	5.30	5.97	1.33	1.99
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	16.63	2.08	8.31	0.00	2.08
Macrophage - monocyte derived, donor1	11232-116C8	26.21	6.38	3.65	1.37	0.23
Macrophage - monocyte derived, donor2	11313-117C8	6.24	13.58	5.51	0.73	0.55
Macrophage - monocyte derived, donor3	11389-118C3	12.45	8.52	3.28	2.10	0.26
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	12.21	0.53	0.53	0.53	1.06
Mallassez-derived cells, donor2	11929-125I3	12.99	2.38	2.06	0.48	0.32
Mallassez-derived cells, donor3	11930-125I4	10.42	1.81	3.06	0.69	1.67
Mammary Epithelial Cell, donor1	11273-116H4	8.67	3.79	2.69	1.59	0.30
Mammary Epithelial Cell, donor2	11350-117G9	10.71	5.79	2.90	1.16	0.87
Mammary Epithelial Cell, donor3	11422-118F9	2.00	2.00	0.75	0.75	0.25
Mast cell - stimulated, donor1	11487-119E2	7.46	35.25	44.74	6.10	2.03
Mast cell, donor1	11563-120D6	25.85	48.45	13.63	6.06	2.60
Mast cell, donor2	11565-120D8	88.26	87.37	21.69	14.26	5.05
Mast cell, donor3	11566-120D9	98.60	74.52	21.84	13.96	8.10
Mast cell, donor4	11567-120E1	106.37	92.01	25.00	19.86	7.45
Mast cell, expanded and stimulated, donor5	11940-126A5	29.16	70.42	21.18	11.42	3.55
Mast cell, expanded and stimulated, donor8	11942-126A7	14.59	38.52	16.34	1.17	2.33
Mast cell, expanded, donor5	11939-126A4	47.95	26.04	9.41	3.44	0.92
Mast cell, expanded, donor8	11941-126A6	52.05	33.98	9.54	5.86	1.34
Melanocyte - dark, donor1	11502-119F8	35.32	1.99	1.39	0.00	0.20
Melanocyte - dark, donor2	11582-120F7	6.23	3.11	1.04	0.35	0.00
Melanocyte - dark, donor3	11663-122F7	16.88	9.63	5.22	4.06	6.52
Melanocyte - light, donor1	11274-116H5	14.34	4.70	0.94	0.94	3.76
Melanocyte - light, donor2	11351-117H1	12.28	0.68	0.00	1.36	0.68
Melanocyte - light, donor3	11423-118G1	6.94	6.07	0.87	0.87	0.00
Melanocyte, donor1 (MC+1)	12641-134G4	13.95	2.92	1.15	0.73	1.35
Melanocyte, donor2 (MC+2)	12739-135I3	12.64	4.30	1.61	1.08	1.88
Melanocyte, donor3 (MC+3)	12837-137B2	20.89	2.68	1.61	0.27	2.41
Meningeal Cells, donor1	11493-119E8	6.20	2.36	0.25	0.99	0.00
Meningeal Cells, donor2	11573-120E7	5.72	3.96	2.20	0.00	0.44
Meningeal Cells, donor3	11654-122E7	7.82	3.50	0.65	0.65	0.08
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	9.12	7.98	2.00	1.14	0.29
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	3.72	2.01	0.81	0.20	0.10
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	3.94	1.31	2.63	1.31	1.31
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	5.23	0.00	0.00	0.00	1.31
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	5.02	3.59	0.72	1.44	0.00
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	6.78	2.33	0.64	0.64	0.00
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	6.53	1.51	0.00	0.50	0.00
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	4.61	1.98	0.66	0.22	0.22
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	0.73	0.73	0.73	0.73	0.00
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	3.07	1.02	0.41	0.20	0.00
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	11.77	2.22	0.97	0.42	0.00
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	7.81	0.74	0.00	0.74	0.00
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	20.53	5.66	1.84	0.26	0.00
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	5.34	1.19	0.59	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	2.34	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	7.04	0.64	0.64	0.00	0.00
Mesenchymal stem cells - adipose, donor0	11217-116B2	11.70	7.44	1.42	1.06	0.00
Mesenchymal stem cells - hepatic, donor0	11218-116B3	20.01	2.81	0.63	0.63	0.00
Mesenchymal stem cells - umbilical, donor0	11214-116A8	5.08	1.45	2.18	0.00	0.00
Mesothelial Cells, donor1	11247-116E5	9.81	1.06	1.86	0.00	0.00
Mesothelial Cells, donor2	12156-128G5	3.50	0.50	0.00	0.00	0.00
Mesothelial Cells, donor3	11402-118D7	8.53	1.59	1.45	0.29	0.22
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	14.85	32.41	21.61	6.75	1.35
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	14.04	13.79	5.66	0.74	0.25
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	12.96	16.20	12.96	2.06	1.47
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	13.83	10.37	10.37	3.46	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	15.19	11.47	5.89	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	9.54	12.86	6.22	1.66	0.62
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	23.16	20.84	11.58	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	13.51	11.01	7.51	1.75	1.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	13.96	11.64	11.64	1.40	1.40
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	97.33	38.93	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	12.40	10.36	7.72	0.61	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	9.50	13.07	7.92	0.40	1.58
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	8.55	25.65	8.55	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	10.62	4.42	3.54	0.88	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	10.26	11.02	9.88	0.76	0.38
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	9.21	3.95	5.26	1.32	2.63
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	8.91	7.22	5.73	0.64	0.85
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	8.29	11.05	4.60	0.92	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	215.66	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	11.33	7.75	4.17	1.49	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	5.03	15.09	8.38	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	101.85	0.00	67.90	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	7.53	7.28	5.77	0.50	1.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	7.84	8.08	7.37	0.71	0.48
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	3.32	3.32	3.32	0.55	0.55
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	6.68	6.91	2.53	0.92	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	7.36	9.68	8.20	1.05	0.42
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	4.08	4.69	3.67	0.61	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	8.37	3.86	4.08	0.43	0.86
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	7.11	5.78	5.78	0.44	0.44
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	0.00	30.96	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	4.16	5.48	4.38	0.66	0.22
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	5.07	4.56	7.60	1.52	0.51
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	4.97	1.66	6.63	1.66	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	8.43	7.34	3.53	1.63	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	5.88	7.06	5.29	0.29	0.59
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	4.36	4.36	3.27	1.09	1.09
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	4.81	1.92	5.29	0.00	0.48
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	10.81	8.00	3.60	0.80	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	5.48	2.74	2.74	1.37	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	7.01	2.50	5.51	0.50	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	2.04	14.27	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	6.57	3.07	3.07	0.44	0.44
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	6.62	5.52	11.04	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	5.76	5.12	1.92	3.20	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	7.93	4.21	3.72	0.74	0.25
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	5.57	4.18	4.87	0.70	0.70
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	0.00	8.84	6.63	6.63	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	5.47	3.08	1.71	0.68	0.34
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	6.56	6.56	4.81	0.44	0.44
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	6.04	5.68	1.78	1.07	1.07
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	6.17	5.05	6.17	0.56	0.56
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	6.23	4.16	3.33	0.42	0.42
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	4.08	8.16	2.91	2.33	1.17
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	8.14	4.22	3.32	1.21	0.30
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	4.17	5.84	2.92	2.09	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	7.22	14.44	14.44	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	9.24	1.85	5.54	1.85	0.92
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	7.97	4.55	4.55	1.71	1.71
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	8.29	5.94	1.24	0.69	0.55
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	7.00	4.41	1.04	0.78	0.52
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	11.15	5.58	2.57	0.43	0.86
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	6.99	6.35	4.45	0.64	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	6.41	9.07	2.94	1.07	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	17.96	8.08	7.18	1.20	1.20
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	6.36	3.67	2.12	0.42	0.28
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	7.96	4.46	2.87	0.64	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	7.30	3.54	2.65	1.33	0.44
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	10.62	5.31	2.28	1.52	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	9.38	5.11	2.84	0.57	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	10.57	3.20	4.42	0.49	0.49
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	11.08	6.52	2.61	1.96	0.65
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	16.76	4.41	2.65	0.59	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	16.72	7.78	5.77	0.58	0.86
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	20.61	9.89	4.12	1.24	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	21.14	5.66	3.28	0.89	0.30
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	11.30	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	7.13	3.56	0.00	1.78	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	10.19	1.31	0.99	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	9.47	4.21	2.10	0.00	1.05
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	18.19	6.72	4.74	0.99	0.59
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	13.04	12.11	9.31	1.86	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	10.89	4.51	4.88	1.50	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	9.32	8.26	4.79	1.33	0.27
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	13.12	4.86	1.47	1.24	0.23
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	8.10	3.68	1.47	0.74	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	11.36	2.93	2.20	0.73	0.37
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	12.44	9.33	6.22	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	4.81	2.67	2.67	1.07	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	3.86	0.00	3.86	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	9.09	1.01	1.01	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	6.32	6.32	2.53	0.84	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	2.72	0.00	1.36	2.72	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	1.91	0.64	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	1.62	0.00	0.81	0.81	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	0.00	4.53	4.53	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	22.84	11.42	5.71	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	9.79	13.05	6.52	0.00	3.26
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	9.50	9.50	4.75	4.75	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	25.10	12.55	37.65	12.55	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	9.48	2.15	0.65	0.22	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	7.84	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	3.34	0.67	1.33	0.00	0.67
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	2.50	5.84	1.25	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	5.32	3.80	0.57	0.57	0.00
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	11.17	0.00	1.60	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	0.68	1.36	0.68	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	7.35	0.00	1.84	1.84	1.84
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	2.93	0.00	1.26	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	3.72	1.16	1.86	1.63	0.46
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	2.97	1.62	1.08	0.81	0.27
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	6.10	2.10	1.26	0.21	0.84
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	6.45	1.99	0.99	0.00	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	5.41	1.89	0.54	0.54	0.54
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	4.31	0.68	1.36	0.23	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	3.76	1.14	1.47	0.49	0.33
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	6.38	1.64	0.73	0.55	0.00
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	3.18	0.00	0.53	0.00	0.00
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	4.80	3.00	0.60	0.60	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	6.89	1.31	0.66	0.00	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	3.25	0.81	0.33	0.33	0.00
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	6.53	2.29	0.71	0.35	0.00
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	2.81	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	2.76	0.46	2.30	0.46	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	3.53	0.64	1.29	0.32	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	5.52	1.72	1.38	0.00	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	12.64	2.53	0.00	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	4.23	1.78	0.67	0.67	0.00
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	3.39	0.85	0.00	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	4.51	1.19	0.71	0.47	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	5.15	1.72	1.29	0.43	0.43
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	2.00	1.67	0.67	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	3.61	0.45	0.90	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	3.17	1.19	1.19	0.00	0.79
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	5.57	0.93	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	3.03	0.76	0.76	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	2.93	0.98	0.65	0.33	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	2.61	2.61	0.44	0.87	0.00
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	1.81	3.17	0.90	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	3.53	0.88	0.00	0.88	0.00
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	5.98	1.99	0.66	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	2.98	0.99	0.99	0.50	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	0.77	0.77	0.00	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	6.65	1.51	0.00	0.30	0.00
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	4.64	1.33	0.88	0.44	0.00
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	4.07	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	5.11	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	5.49	2.44	1.22	0.61	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	3.15	1.57	0.63	0.31	0.31
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	4.84	2.42	0.61	0.30	0.00
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	2.37	0.79	1.58	0.79	0.00
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	5.67	2.27	1.13	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	0.00	0.00	0.00	0.00	0.00
Myoblast, donor1	11241-116D8	6.34	1.49	1.12	0.25	0.00
Myoblast, donor2	11322-117D8	7.86	3.26	0.00	0.19	0.19
Myoblast, donor3	11398-118D3	3.87	1.68	0.34	1.35	0.00
NK T cell leukemia cell line:KHYG-1	10777-110G3	11.82	14.01	8.32	1.61	0.58
Natural Killer Cells, donor1	11230-116C6	70.42	43.36	33.21	5.23	1.54
Natural Killer Cells, donor2	11311-117C6	60.61	30.46	26.84	1.81	1.81
Natural Killer Cells, donor3	11387-118C1	64.42	48.59	29.08	3.13	3.68
Neural stem cells, donor1	11275-116H6	26.86	11.61	2.54	1.09	0.73
Neural stem cells, donor2	11352-117H2	23.11	5.78	0.00	0.00	0.00
Neurons, donor1	11494-119E9	7.97	3.41	2.28	1.14	1.14
Neurons, donor2	11574-120E8	6.16	1.54	0.88	0.44	0.00
Neurons, donor3	11655-122E8	1.64	4.93	0.82	0.00	0.82
Neutrophils, donor1	11233-116C9	324.80	33.41	78.88	2.78	2.78
Neutrophils, donor2	11314-117C9	185.53	26.09	37.69	0.00	2.90
Neutrophils, donor3	11390-118C4	298.09	21.38	61.70	3.05	1.22
Nucleus Pulposus Cell, donor1	11252-116F1	16.62	5.58	1.19	1.42	0.36
Nucleus Pulposus Cell, donor2	11409-118E5	9.44	2.60	0.98	0.33	0.33
Nucleus Pulposus Cell, donor3	11462-119B4	5.01	2.41	0.20	0.40	0.00
Olfactory epithelial cells, donor1	11933-125I7	5.92	0.69	1.79	0.28	0.14
Olfactory epithelial cells, donor2	11934-125I8	4.05	1.59	1.88	0.58	0.43
Olfactory epithelial cells, donor3	11935-125I9	8.17	1.36	0.23	0.34	0.34
Olfactory epithelial cells, donor4	11936-126A1	8.77	1.75	1.17	0.68	0.29
Oligodendrocyte - precursors, donor1	11496-119F2	15.05	4.81	2.41	1.20	0.00
Osteoblast - differentiated, donor1	11276-116H7	4.25	1.91	1.28	0.43	0.00
Osteoblast - differentiated, donor2	11353-117H3	2.29	2.29	0.00	0.00	0.00
Osteoblast - differentiated, donor3	11425-118G3	11.17	4.34	2.48	0.00	0.00
Osteoblast, donor1	11277-116H8	1.56	1.37	0.39	0.00	0.00
Osteoblast, donor2	11354-117H4	5.62	5.62	1.40	0.00	0.00
Osteoblast, donor3	11426-118G4	5.33	5.15	1.60	0.36	0.00
Pancreatic stromal cells, donor1	11249-116E7	16.26	3.79	1.10	0.84	0.51
Pericytes, donor1	11491-119E6	9.46	2.00	0.89	1.00	0.89
Pericytes, donor2	11571-120E5	9.51	2.72	1.13	0.68	0.68
Pericytes, donor3	11652-122E5	7.12	1.63	0.20	0.20	0.00
Perineurial Cells, donor1	11499-119F5	10.96	3.05	0.90	0.79	0.00
Perineurial Cells, donor2	11579-120F4	11.59	3.77	1.75	0.74	0.00
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	80.96	16.89	21.99	1.59	0.96
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	58.52	11.75	16.16	0.49	0.49
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	47.75	16.44	15.79	1.81	0.65
Placental Epithelial Cells, donor1	11278-116H9	6.70	0.96	1.43	0.72	0.00
Placental Epithelial Cells, donor2	11355-117H5	4.44	0.00	0.00	0.00	0.00
Placental Epithelial Cells, donor3	11427-118G5	3.14	0.39	0.39	0.00	0.00
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	9.49	2.85	0.95	0.32	0.00
Preadipocyte - breast, donor1	11467-119B9	7.32	1.88	0.75	0.19	0.19
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	5.87	1.96	0.39	0.52	0.00
Preadipocyte - breast, donor2	11328-117E5	6.08	2.25	0.45	0.00	0.00
Preadipocyte - omental, donor1	11468-119C1	10.55	1.70	0.85	0.11	0.11
Preadipocyte - omental, donor2	11329-117E6	13.09	3.49	0.44	0.44	0.00
Preadipocyte - omental, donor3	11403-118D8	7.31	1.29	1.15	0.14	0.14
Preadipocyte - perirenal, donor1	11469-119C2	5.91	0.98	0.00	0.00	0.00
Preadipocyte - subcutaneous, donor1	11279-116I1	1.54	1.23	0.00	0.00	0.31
Preadipocyte - subcutaneous, donor2	11356-117H6	6.02	5.67	1.06	1.06	0.18
Preadipocyte - subcutaneous, donor3	11428-118G6	4.09	4.94	1.19	0.17	0.17
Preadipocyte - visceral, donor1	11280-116I2	11.64	6.33	2.24	0.65	0.28
Preadipocyte - visceral, donor2	11357-117H7	2.76	2.76	0.92	0.46	0.00
Preadipocyte - visceral, donor3	11429-118G7	5.85	3.66	1.04	0.73	0.21
Prostate Epithelial Cells (polarized), donor1	11253-116F2	19.91	3.62	3.92	1.06	0.91
Prostate Epithelial Cells, donor2	11331-117E8	4.20	0.81	1.49	0.54	0.54
Prostate Epithelial Cells, donor3	11404-118D9	11.39	2.39	1.90	0.24	0.24
Prostate Stromal Cells, donor1	11254-116F3	14.92	6.95	1.48	0.68	0.00
Prostate Stromal Cells, donor2	11332-117E9	10.04	5.92	1.97	1.08	0.00
Prostate Stromal Cells, donor3	11405-118E1	19.19	6.05	2.40	1.15	0.52
Renal Cortical Epithelial Cells, donor1	11516-119H4	8.76	1.09	0.73	0.36	0.00
Renal Cortical Epithelial Cells, donor2	11596-120H3	21.56	3.47	1.87	0.69	0.21
Renal Epithelial Cells, donor1	11517-119H5	5.58	2.03	1.52	0.00	1.01
Renal Epithelial Cells, donor2	11597-120H4	8.54	0.71	1.42	0.00	0.00
Renal Epithelial Cells, donor3	11678-122H4	21.81	3.28	1.16	0.74	0.21
Renal Glomerular Endothelial Cells, donor1	11514-119H2	12.26	2.04	1.36	0.68	0.68
Renal Glomerular Endothelial Cells, donor2	11594-120H1	15.90	1.35	1.48	0.13	0.13
Renal Glomerular Endothelial Cells, donor3	11675-122H1	16.87	5.33	2.44	0.44	0.22
Renal Glomerular Endothelial Cells, donor4	11783-124B1	5.32	2.00	0.00	0.00	0.00
Renal Mesangial Cells, donor1	11518-119H6	7.04	2.42	0.44	0.22	0.22
Renal Mesangial Cells, donor2	11598-120H5	8.15	3.13	0.63	0.63	0.00
Renal Mesangial Cells, donor3	11679-122H5	2.50	0.55	0.83	0.00	0.28
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	18.25	3.76	1.88	0.81	0.54
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	13.92	2.11	0.84	0.42	0.00
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	8.49	0.77	0.58	0.19	0.19
Retinal Pigment Epithelial Cells, donor0	11215-116A9	35.78	3.89	2.07	1.04	0.00
Retinal Pigment Epithelial Cells, donor1	11528-119I7	14.21	1.14	0.85	0.57	0.00
Retinal Pigment Epithelial Cells, donor2	11608-120I6	7.20	1.03	1.03	0.00	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	21.08	2.01	1.25	0.25	0.00
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	66.28	7.88	8.82	1.34	0.94
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	12.51	8.93	0.89	3.57	0.89
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	20.36	3.85	1.65	0.00	0.55
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	20.30	11.02	1.74	0.00	0.58
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	11.31	5.07	0.91	1.56	0.39
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	11.22	6.55	0.89	1.29	0.10
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	14.83	9.59	1.34	1.78	0.11
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	13.40	8.93	1.61	1.74	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	10.02	8.86	0.70	0.93	0.35
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	13.41	8.32	1.85	1.62	0.46
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	11.64	5.89	1.51	1.92	0.55
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	10.14	9.23	1.21	1.36	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	13.26	9.32	2.15	2.15	0.72
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	14.63	6.74	0.72	1.15	0.29
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	12.23	7.83	1.07	0.97	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	12.39	5.75	0.66	1.33	0.66
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	9.75	6.50	0.76	1.53	0.38
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	10.53	6.24	1.49	1.30	0.28
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	19.92	6.58	2.63	1.50	0.56
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	12.21	6.10	1.06	1.33	0.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	9.93	6.72	1.65	1.36	0.39
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	11.65	7.64	1.53	1.15	0.57
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	13.78	5.45	0.64	1.07	0.11
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	10.65	5.61	0.84	0.84	0.28
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	9.57	6.67	1.88	0.68	0.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	12.03	6.02	0.55	1.09	0.36
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	12.02	6.62	0.98	1.23	0.25
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	14.91	7.66	1.07	1.21	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	17.93	6.37	1.42	1.18	0.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	9.13	5.75	0.60	0.99	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	16.37	9.82	1.40	1.17	0.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	12.03	8.71	2.07	0.21	0.41
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	9.95	5.97	0.88	0.44	0.44
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	11.70	8.77	0.84	0.84	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	15.61	6.06	1.21	1.48	0.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	12.26	6.13	1.70	1.19	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	12.15	6.94	1.74	0.19	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	15.99	4.13	1.55	0.34	0.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	11.66	6.45	1.65	0.55	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	14.61	6.57	1.15	0.49	0.16
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	12.61	6.48	1.02	2.39	0.51
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	12.28	7.99	1.33	0.74	0.15
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	15.19	6.66	0.53	1.33	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	18.11	8.71	0.97	1.94	0.69
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	18.10	8.33	0.48	0.95	0.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	16.32	6.65	1.41	0.81	0.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	18.46	9.98	1.22	1.13	0.28
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	19.91	10.83	4.19	0.70	1.05
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	12.39	9.07	2.42	1.81	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	22.03	9.91	1.35	1.35	0.61
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	41.48	20.67	4.80	2.47	1.89
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	23.73	9.13	0.61	2.43	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	17.48	10.55	1.21	1.51	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	21.94	11.54	2.49	2.26	0.68
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	21.87	11.98	2.40	3.29	1.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	22.08	13.81	2.60	2.48	0.35
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	22.84	14.73	3.63	2.77	0.43
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	31.85	13.22	4.21	1.80	1.20
Schwann Cells, donor1	11498-119F4	3.20	0.94	0.19	0.38	0.00
Schwann Cells, donor2	11578-120F3	6.80	0.00	0.00	0.00	0.00
Schwann Cells, donor3	11659-122F3	5.26	0.88	0.22	0.22	0.44
Sebocyte, donor1	11220-116B5	6.57	1.10	1.64	1.64	0.55
Sebocyte, donor2	11301-117B5	3.22	0.92	0.92	0.92	0.92
Sebocyte, donor3	11378-118B1	5.57	1.03	0.82	0.21	0.00
Sertoli Cells, donor1	11255-116F4	11.60	1.66	6.63	0.00	0.00
Sertoli Cells, donor2	11333-117F1	5.65	2.82	0.00	0.00	0.00
Skeletal Muscle Cells, donor1	11281-116I3	4.75	2.20	0.18	0.00	0.09
Skeletal Muscle Cells, donor2	11358-117H8	2.89	0.72	0.00	0.00	0.00
Skeletal Muscle Cells, donor3	11430-118G8	5.85	0.84	0.84	0.00	0.00
Skeletal Muscle Cells, donor4	11451-119A2	8.01	3.46	0.79	0.63	0.16
Skeletal Muscle Cells, donor5	11455-119A6	8.03	3.86	0.89	0.59	0.15
Skeletal Muscle Cells, donor6	11459-119B1	5.54	2.77	1.69	0.62	0.15
Skeletal Muscle Satellite Cells, donor1	11240-116D7	15.50	3.78	0.63	0.25	0.00
Skeletal Muscle Satellite Cells, donor2	11321-117D7	12.84	4.85	1.43	0.71	0.00
Skeletal Muscle Satellite Cells, donor3	11397-118D2	7.44	6.75	0.99	0.79	0.20
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	5.98	1.35	0.25	0.25	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	3.62	2.17	0.72	0.00	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	2.89	1.38	0.96	0.14	0.14
Skin - palm, donor1	10286-104F7	21.49	13.43	10.74	5.37	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	4.32	2.02	1.59	0.72	0.29
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	33.53	7.36	4.91	0.82	0.82
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	6.88	2.73	1.95	1.04	0.52
Small Airway Epithelial Cells, donor1	11256-116F5	10.56	3.61	4.17	1.39	0.14
Small Airway Epithelial Cells, donor2	11334-117F2	8.02	5.34	3.38	1.13	0.56
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	18.18	6.55	4.86	3.17	0.85
Small Airway Epithelial Cells, donor3	11406-118E2	10.42	5.92	5.85	1.65	0.60
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	8.95	0.62	0.31	0.62	0.00
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	4.45	0.89	0.22	0.00	0.00
Smooth Muscle Cells - Aortic, donor0	11210-116A4	7.64	0.59	0.59	0.00	0.00
Smooth Muscle Cells - Aortic, donor1	11283-116I5	4.64	0.66	0.66	0.44	0.00
Smooth Muscle Cells - Aortic, donor2	11360-117I1	2.76	0.39	0.00	0.00	0.00
Smooth Muscle Cells - Aortic, donor3	11432-118H1	5.41	0.00	1.55	0.00	0.00
Smooth Muscle Cells - Bladder, donor1	11519-119H7	42.03	5.00	2.00	1.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	2.66	1.33	0.67	0.13	0.00
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	5.54	1.99	0.66	0.22	0.00
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	4.87	2.30	1.79	0.26	0.26
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	14.98	6.19	0.98	1.30	0.98
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	7.38	1.48	0.59	0.89	0.00
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	10.11	1.14	1.00	0.14	0.14
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	2.93	2.28	0.65	0.16	0.00
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	9.13	1.83	1.52	1.52	0.30
Smooth Muscle Cells - Carotid, donor1	11285-116I7	6.57	1.77	0.51	0.25	0.00
Smooth Muscle Cells - Carotid, donor2	11362-117I3	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	1.91	1.91	0.00	0.00	0.00
Smooth Muscle Cells - Colonic, donor1	11239-116D6	12.83	2.80	0.59	0.74	0.00
Smooth Muscle Cells - Colonic, donor2	11320-117D6	7.96	3.01	0.43	0.22	0.00
Smooth Muscle Cells - Colonic, donor3	11396-118D1	10.92	2.10	1.26	0.52	0.10
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	2.47	0.46	0.46	0.15	0.00
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	3.23	2.16	1.08	0.00	0.00
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	4.48	0.90	0.00	0.30	0.00
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	4.44	0.68	0.34	0.00	0.00
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	23.24	3.85	1.10	0.63	0.00
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	9.76	3.12	2.82	0.60	0.10
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	8.87	1.37	0.00	0.68	0.46
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	0.60	1.21	0.00	0.00	0.00
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	9.54	4.50	1.06	0.26	0.00
Smooth Muscle Cells - Prostate, donor1	11257-116F6	11.58	7.32	2.00	1.60	0.80
Smooth Muscle Cells - Prostate, donor2	11335-117F3	18.41	5.63	1.88	0.63	0.25
Smooth Muscle Cells - Prostate, donor3	11465-119B7	9.64	2.79	1.01	0.25	0.25
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	9.95	4.22	1.36	0.00	0.30
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	3.75	0.75	0.00	0.00	0.00
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	15.51	1.29	5.17	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	2.33	2.79	0.47	0.47	0.00
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	4.04	0.00	0.50	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	3.45	0.94	1.25	0.00	0.00
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	5.01	2.06	0.00	0.00	0.29
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	8.33	5.41	2.08	0.33	0.00
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	11.68	2.34	1.40	0.47	0.00
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	2.88	0.43	1.30	0.14	0.00
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	5.35	2.55	1.27	0.00	0.00
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	1.32	0.56	0.56	0.00	0.19
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	9.64	2.24	1.12	0.00	0.42
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	12.15	4.02	1.34	0.25	0.08
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	3.33	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	4.16	0.73	0.49	0.00	0.00
Smooth Muscle Cells - Uterine, donor1	11258-116F7	3.98	3.98	2.87	0.22	0.00
Smooth Muscle Cells - Uterine, donor3	11466-119B8	4.39	2.63	0.29	0.29	0.00
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	13.80	1.75	0.97	0.39	0.39
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	7.14	2.91	0.53	0.26	0.00
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	5.21	2.60	0.37	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	14.37	2.16	1.80	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	9.37	2.27	2.27	0.28	0.00
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	5.91	3.15	1.58	0.39	0.39
Smooth muscle cells - airway, control, donor1	11966-126D4	11.94	1.52	0.25	0.51	0.00
Smooth muscle cells - airway, control, donor2	11967-126D5	13.58	2.40	0.80	0.40	0.00
Smooth muscle cells - airway, control, donor3	11968-126D6	7.52	2.09	1.25	0.42	0.00
Smooth muscle cells - airway, control, donor4	11969-126D7	16.04	2.75	0.92	0.92	0.00
Synoviocyte, donor1	11291-117A4	11.95	3.20	3.53	1.18	0.50
Synoviocyte, donor2	11368-117I9	10.06	3.02	1.34	0.34	0.17
Synoviocyte, donor3	11440-118H9	9.38	1.12	2.23	0.45	0.22
Trabecular Meshwork Cells, donor1	11532-120A2	7.50	2.86	0.36	1.79	0.00
Trabecular Meshwork Cells, donor2	11612-122A1	5.95	0.00	0.00	0.00	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	4.86	2.08	0.23	0.93	0.00
Tracheal Epithelial Cells, donor1	11292-117A5	7.10	2.51	1.43	0.72	0.22
Tracheal Epithelial Cells, donor2	11369-118A1	5.41	1.16	0.39	0.00	0.00
Tracheal Epithelial Cells, donor3	11441-118I1	1.72	2.29	0.00	1.15	0.00
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	72.58	6.27	7.75	1.97	0.98
Urethra, donor2	10319-105A4	21.58	3.60	14.39	1.80	0.00
Urothelial Cells, donor1	11520-119H8	3.98	1.33	0.27	0.53	0.00
Urothelial Cells, donor2	11600-120H7	4.41	0.00	0.40	1.60	0.40
Urothelial Cells, donor3	11681-122H7	4.81	1.60	0.23	0.46	0.00
Urothelial cells, donor0	11216-116B1	11.59	7.58	1.78	1.78	0.22
Whole blood (ribopure), donor090309, donation1	12179-129A1	188.63	17.80	40.04	1.78	0.89
Whole blood (ribopure), donor090309, donation2	12180-129A2	233.03	25.73	30.02	4.29	2.86
Whole blood (ribopure), donor090309, donation3	12181-129A3	125.27	15.74	19.85	2.05	2.05
Whole blood (ribopure), donor090325, donation1	12176-128I7	100.20	14.46	15.84	1.38	0.34
Whole blood (ribopure), donor090325, donation2	12177-128I8	123.18	8.72	26.15	1.74	0.58
Whole blood (ribopure), donor090612, donation1	12182-129A4	200.96	20.82	26.03	0.00	2.08
Whole blood (ribopure), donor090612, donation2	12183-129A5	167.96	24.78	22.03	4.59	0.92
Whole blood (ribopure), donor090612, donation3	12184-129A6	94.03	18.26	13.69	0.00	2.74
Wilms' tumor cell line:G-401	10809-111A8	16.53	7.15	1.97	2.47	0.86
Wilms' tumor cell line:HFWT	10597-108E3	8.80	10.56	0.00	1.76	0.00
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	14.25	5.31	3.63	2.23	1.12
achilles tendon, donor2	10292-104G4	24.80	12.40	8.27	0.00	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	25.24	9.18	2.80	0.51	0.00
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	19.50	5.11	0.70	0.46	0.00
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	32.17	6.05	2.85	0.24	0.12
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	27.48	7.62	2.72	0.00	0.00
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	26.14	16.30	1.97	1.69	0.28
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	28.13	11.42	5.29	1.48	1.27
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	45.73	14.16	4.63	1.91	1.36
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	18.51	6.17	2.20	0.00	0.00
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	20.01	11.43	3.68	1.23	0.41
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	23.69	4.66	3.88	1.16	0.39
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	26.50	5.52	3.50	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	27.30	11.70	3.90	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	15.57	5.81	1.63	0.70	0.23
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	30.29	5.70	2.07	1.29	0.00
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	25.43	2.05	1.46	0.29	0.00
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	21.84	5.58	2.79	0.00	0.46
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	20.97	12.75	3.70	1.23	0.82
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	27.01	9.52	4.91	1.23	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	28.59	9.81	4.69	0.85	0.85
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	40.03	10.31	3.64	2.12	0.61
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	36.59	15.65	5.05	0.96	0.48
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	27.40	4.45	2.67	0.22	0.22
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	8.67	11.34	3.34	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	33.45	7.43	0.00	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	42.56	7.16	0.38	0.38	0.38
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	61.06	14.83	2.62	3.05	1.31
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	13.12	7.50	5.62	0.00	0.00
adenocarcinoma cell line:IM95m	10796-110I4	22.61	8.71	9.18	2.12	0.24
adipose tissue, adult, pool1	10010-101C1	90.90	9.31	4.65	1.55	1.86
adipose, donor1	10184-103D4	16.42	2.35	1.17	0.59	0.00
adipose, donor2	10185-103D5	10.95	3.65	0.41	1.22	0.00
adipose, donor3	10186-103D6	9.80	0.54	0.82	0.54	0.00
adipose, donor4	10187-103D7	22.54	5.20	0.87	0.87	0.00
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	16.10	5.68	0.47	0.95	0.00
adrenal gland, adult, pool1	10081-102A9	25.46	0.00	3.64	0.00	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	30.95	6.67	1.87	0.40	0.27
alveolar cell carcinoma cell line:SW 1573	10708-109H6	8.22	5.00	0.36	1.07	0.36
amniotic membrane cells, donor1	12235-129G3	20.17	1.16	1.39	1.16	0.46
amniotic membrane cells, donor2	12236-129G4	16.23	1.69	1.01	0.00	0.68
amniotic membrane cells, donor3	12237-129G5	22.68	0.29	0.59	0.29	0.88
amygdala - adult, donor10196	10167-103B5	37.95	5.93	7.11	1.19	0.00
amygdala, adult, donor10252	10151-102I7	42.78	9.94	2.84	0.20	1.01
amygdala, newborn, donor10223	10360-105E9	26.79	4.52	5.49	0.97	0.97
anaplastic carcinoma cell line:8305C	10428-106D5	38.84	7.39	1.27	1.27	0.25
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	16.33	12.13	1.32	1.32	0.66
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	7.35	7.68	2.34	1.00	0.00
aorta, adult, pool1	10052-101G7	35.11	5.30	6.47	1.18	0.20
appendix, adult	10189-103D9	61.32	14.75	11.64	0.00	0.39
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	30.95	2.41	4.13	0.34	0.34
artery, adult	10190-103E1	73.37	10.87	4.08	1.36	0.00
astrocytoma cell line:TM-31	10425-106D2	7.10	5.07	2.03	0.72	0.43
b cell line:RPMI1788	10427-106D4	17.70	12.94	2.08	0.59	0.59
basal cell carcinoma cell line:TE 354.T	10702-109G9	9.16	4.72	1.94	1.94	0.55
bile duct carcinoma cell line:HuCCT1	10432-106D9	19.25	8.73	7.05	1.49	0.30
bile duct carcinoma cell line:TFK-1	10496-107C1	29.96	11.21	12.55	3.68	0.84
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	20.13	11.18	1.68	0.56	0.56
bladder, adult, pool1	10011-101C2	60.95	7.28	6.84	2.06	0.33
blood, adult, pool1	10053-101G8	31.00	4.43	11.07	0.00	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	12.85	7.71	4.28	1.71	0.00
bone marrow, adult	10192-103E3	60.06	11.47	0.67	1.35	0.67
brain, adult, donor1	10084-102B3	30.75	3.08	5.13	3.08	0.00
brain, adult, pool1	10012-101C3	22.05	7.24	3.56	0.89	0.22
brain, fetal, pool1	10085-102B4	29.39	2.67	0.00	0.00	0.00
breast carcinoma cell line:MCF7	10482-107A5	15.20	1.65	4.96	1.65	0.99
breast carcinoma cell line:MDA-MB-453	10419-106C5	78.01	4.99	23.97	2.12	1.25
breast, adult, donor1	10080-102A8	43.56	6.31	5.68	0.63	1.89
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	10.54	4.95	5.59	3.30	0.51
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	7.42	1.55	4.95	0.31	0.00
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	10.82	1.38	0.00	0.46	0.23
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	16.70	4.84	1.45	0.97	0.48
carcinoid cell line:NCI-H1770	10703-109H1	22.10	1.41	0.47	0.00	0.00
carcinoid cell line:NCI-H727	10735-110B6	17.28	3.39	4.59	0.44	0.00
carcinoid cell line:SK-PN-DW	10719-109I8	8.56	0.95	0.32	0.00	0.00
carcinosarcoma cell line:JHUCS-1	10642-109A3	5.86	0.80	0.53	0.27	0.00
caudate nucleus - adult, donor10196	10177-103C6	36.84	6.91	6.91	0.00	0.00
caudate nucleus, adult, donor10252	10164-103B2	37.65	9.20	5.52	2.34	0.17
caudate nucleus, adult, donor10258	10379-105H1	44.32	8.41	12.23	0.00	0.76
caudate nucleus, newborn, donor10223	10354-105E3	35.16	5.49	3.66	1.83	0.73
cerebellum - adult, donor10196	10173-103C2	46.61	0.00	2.91	0.00	0.00
cerebellum, adult, donor10252	10166-103B4	65.12	3.63	2.99	0.00	0.21
cerebellum, adult, pool1	10083-102B2	21.73	2.07	3.10	0.34	0.00
cerebellum, newborn, donor10223	10357-105E6	50.65	5.81	6.64	0.00	0.00
cerebral meninges, adult	10188-103D8	28.24	8.82	5.55	0.50	0.25
cerebrospinal fluid, donor2	10294-104G6	21.20	0.00	4.39	0.73	0.00
cervical cancer cell line:D98-AH2	10552-107I3	13.95	4.31	6.33	1.15	1.01
cervical cancer cell line:ME-180	10553-107I4	19.06	4.64	7.46	2.15	1.49
cervix, adult, pool1	10013-101C4	57.53	6.82	4.09	1.36	0.21
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	2.37	2.79	0.42	0.56	0.14
chondrosarcoma cell line:SW 1353	10700-109G7	3.92	0.00	0.00	0.00	0.00
choriocarcinoma cell line:BeWo	10423-106C9	89.60	3.98	4.10	1.24	0.99
choriocarcinoma cell line:SCH	10785-110H2	17.62	0.49	0.86	0.25	0.00
choriocarcinoma cell line:T3M-3	10618-108G6	25.38	0.95	1.66	0.24	0.00
chorionic membrane cells, donor1	12238-129G6	25.93	2.28	0.85	1.14	0.85
chorionic membrane cells, donor2	12239-129G7	12.23	2.68	1.39	0.50	0.20
chorionic membrane cells, donor3	12240-129G8	34.62	2.75	2.20	0.00	0.00
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	24.24	7.07	8.08	1.01	0.00
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	18.06	16.33	6.92	1.92	0.77
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	19.43	11.40	9.08	1.06	0.84
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	54.70	15.66	3.60	1.03	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	50.79	11.85	4.35	0.73	0.24
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	49.07	16.09	5.29	0.00	0.00
chronic myelogenous leukemia cell line:K562	10454-106G4	32.39	5.59	2.36	0.00	0.00
chronic myelogenous leukemia cell line:KU812	10409-106B4	40.40	10.69	10.16	0.52	0.78
clear cell carcinoma cell line:JHOC-5	10638-108I8	23.09	5.49	2.51	0.91	0.69
clear cell carcinoma cell line:TEN	10636-108I6	17.35	7.29	2.95	2.08	0.17
colon carcinoma cell line:CACO-2	10513-107D9	44.48	6.59	7.50	2.20	1.65
colon carcinoma cell line:COLO-320	10420-106C6	22.42	5.70	0.38	0.00	0.00
colon, adult, donor1	10082-102B1	39.27	3.57	5.95	1.19	0.00
colon, adult, pool1	10014-101C5	61.81	7.17	8.23	1.18	0.59
colon, fetal, donor1	10070-101I7	40.79	2.47	4.33	1.85	1.24
common myeloid progenitor CMP, donor1	12130-128D6	206.26	91.67	59.59	0.00	0.00
common myeloid progenitor CMP, donor2	12134-128E1	50.07	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	8.50	17.85	5.52	1.70	0.42
cord blood derived cell line:COBL-a 24h infection	10453-106G3	7.85	11.92	6.49	0.60	0.30
cord blood derived cell line:COBL-a untreated	10449-106F8	8.88	13.96	5.92	0.42	0.56
corpus callosum, adult, pool1	10042-101F6	54.84	13.82	9.62	1.77	0.33
cruciate ligament, donor2	10295-104G7	45.39	8.92	5.67	0.00	0.00
diaphragm, fetal, donor1	10069-101I6	62.60	2.41	1.61	2.41	0.00
diencephalon, adult	10193-103E4	38.16	5.52	5.04	0.72	0.24
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	22.27	4.13	4.36	0.69	0.00
ductal cell carcinoma cell line:KLM-1	10438-106E6	22.82	7.18	6.15	2.56	2.05
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	11.31	4.81	1.69	1.69	0.96
ductus deferens, adult	10196-103E7	45.85	4.49	6.48	1.00	1.50
duodenum, fetal, donor1, tech_rep1	10071-101I8	36.01	2.88	7.20	1.44	0.00
duodenum, fetal, donor1, tech_rep2	10071-101I8	64.00	5.15	7.36	0.00	0.00
dura mater, adult, donor1	10041-101F5	27.67	9.41	3.88	0.99	0.91
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	25.09	3.55	6.88	0.89	1.33
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	20.35	2.87	2.01	1.15	0.43
embryonic pancreas cell line:1B2C6	10604-108F1	12.95	4.93	0.00	1.85	0.00
embryonic pancreas cell line:1C3D3	10605-108F2	6.66	4.24	1.21	0.91	0.91
embryonic pancreas cell line:1C3IKEI	10606-108F3	7.41	6.79	0.93	2.78	0.00
embryonic pancreas cell line:2C6	10603-108E9	7.88	5.25	0.00	2.63	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	17.43	11.73	2.35	1.01	0.34
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	15.95	7.97	2.90	1.63	0.00
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	24.12	5.63	2.57	0.64	0.80
epidermoid carcinoma cell line:A431	10426-106D3	15.78	10.56	4.22	4.89	3.56
epidermoid carcinoma cell line:Ca Ski	10431-106D8	14.74	4.95	3.52	2.64	1.87
epididymis, adult	10197-103E8	35.79	3.14	2.72	0.00	0.21
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	26.43	12.77	3.02	3.19	0.35
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	7.86	2.36	0.39	2.36	1.18
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	23.72	5.50	3.80	1.44	0.39
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	27.07	5.71	4.13	1.57	0.59
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	27.22	6.39	3.25	2.24	0.78
esophagus, adult, pool1	10015-101C6	82.18	5.52	6.90	1.27	0.85
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	20.79	4.88	0.75	1.50	0.50
eye - muscle inferior rectus, donor1	10272-104E2	24.15	4.83	7.24	0.00	0.00
eye - muscle lateral, donor2	10298-104H1	23.15	6.31	2.10	0.00	0.00
eye - muscle medial, donor2	10299-104H2	37.21	1.49	1.49	0.00	1.49
eye - muscle superior, donor2	10297-104G9	33.25	1.15	3.44	0.00	0.00
eye - vitreous humor, donor1	10268-104D7	26.23	8.74	2.91	1.46	2.91
eye, fetal, donor1	10054-101G9	26.19	2.29	1.53	0.51	0.00
fibrosarcoma cell line:HT-1080	10758-110E2	2.82	1.41	0.64	0.13	0.00
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	6.65	0.95	1.42	0.24	0.24
frontal lobe, adult, pool1	10040-101F4	36.12	7.60	5.44	0.47	0.28
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	31.23	2.10	4.50	0.60	1.80
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	9.88	10.61	1.01	1.74	0.82
gall bladder, adult	10198-103E9	56.25	8.21	7.73	2.17	0.24
gamma delta positive T cells, donor1	11937-126A2	77.31	47.78	25.23	3.76	1.07
gamma delta positive T cells, donor2	11938-126A3	71.34	51.17	19.05	6.72	4.11
gastric adenocarcinoma cell line:MKN1	10614-108G2	10.98	5.28	1.90	1.06	0.42
gastric adenocarcinoma cell line:MKN45	10612-108F9	14.12	12.57	16.25	1.35	0.00
gastric cancer cell line:AZ521	10549-107H9	18.36	10.82	1.80	1.31	0.33
gastric cancer cell line:GSS	10560-108A2	21.97	2.75	0.00	0.00	0.00
gastrointestinal carcinoma cell line:ECC12	10615-108G3	59.40	6.17	5.94	1.37	0.69
giant cell carcinoma cell line:LU65	10487-107B1	11.13	5.74	1.95	0.23	0.00
giant cell carcinoma cell line:Lu99B	10433-106E1	12.32	5.74	1.96	0.98	0.00
glassy cell carcinoma cell line:HOKUG	10688-109F4	14.22	5.49	3.99	1.25	0.00
glioblastoma cell line:A172, tech_rep1	10444-106F3	7.71	2.74	0.42	0.84	0.21
glioblastoma cell line:A172, tech_rep2	10444-106F3	7.16	2.53	0.70	0.84	0.00
glioblastoma cell line:T98G	10485-107A8	10.26	4.97	1.55	1.99	0.66
glioma cell line:GI-1	10413-106B8	7.32	4.69	1.76	1.17	0.00
globus pallidus - adult, donor10196	10175-103C4	27.70	5.10	5.10	0.73	0.00
globus pallidus, adult, donor10252	10161-103A8	67.37	8.79	6.35	0.49	0.49
globus pallidus, adult, donor10258	10367-105F7	47.92	8.22	5.48	0.00	0.00
globus pallidus, newborn, donor10223	10364-105F4	39.44	3.73	3.73	1.60	0.53
granulocyte macrophage progenitor, donor1	12131-128D7	122.36	48.94	41.60	7.34	0.00
granulocyte macrophage progenitor, donor2	12135-128E2	32.79	10.93	10.93	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	15.68	10.45	0.00	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	6.72	1.92	1.60	0.64	0.00
hIPS +CCl2, biol_rep1	14383-156B9	34.89	4.59	6.89	0.46	0.00
hIPS +CCl2, biol_rep2	14384-156C1	37.50	5.03	3.66	0.46	0.46
hIPS +CCl2, biol_rep3	14385-156C2	31.56	2.58	6.44	0.00	0.00
hIPS, biol_rep1	14380-156B6	34.49	2.87	5.75	1.44	0.00
hIPS, biol_rep2	14381-156B7	30.86	6.17	4.12	0.69	0.00
hIPS, biol_rep3	14382-156B8	38.62	11.03	7.72	2.21	1.10
hairy cell leukemia cell line:Mo	10712-109I1	8.33	6.90	3.74	0.29	0.00
heart - mitral valve, adult	10205-103F7	61.29	4.78	1.20	0.90	0.90
heart - pulmonic valve, adult	10206-103F8	78.97	9.94	10.20	1.05	0.78
heart - tricuspid valve, adult	10207-103F9	55.79	9.99	1.67	2.50	0.83
heart, adult, diseased post-infarction, donor1	10050-101G5	26.12	3.26	2.45	0.82	1.02
heart, adult, diseased, donor1	10051-101G6	47.27	2.98	2.13	2.13	0.00
heart, adult, pool1	10016-101C7	69.22	10.81	7.36	1.38	0.69
heart, fetal, pool1	10046-101G1	143.14	15.20	8.73	1.03	0.31
hepatic mesenchymal tumor cell line:LI90	10778-110G4	6.48	1.23	0.62	0.00	0.00
hepatoblastoma cell line:HuH-6	10633-108I3	30.92	2.38	3.57	0.00	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	22.43	3.09	1.99	0.33	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	25.61	3.03	2.67	0.36	0.12
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	27.39	3.33	2.12	0.61	0.30
hepatoma cell line:Li-7	10484-107A7	19.46	6.23	6.90	1.89	0.33
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	12.56	7.64	1.11	0.60	0.20
hippocampus - adult, donor10196	10169-103B7	18.93	1.89	1.89	0.95	0.00
hippocampus, adult, donor10252	10153-102I9	58.37	11.43	3.67	1.43	0.00
hippocampus, adult, donor10258	10374-105G5	29.38	2.99	1.49	0.00	0.00
hippocampus, newborn, donor10223	10363-105F3	22.91	4.23	4.93	0.35	1.06
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	45.78	4.27	4.27	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	32.01	3.53	5.50	0.59	0.20
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	39.10	5.33	3.81	0.76	0.25
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	12.97	1.13	0.56	0.56	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	11.88	1.81	2.32	0.52	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	18.98	4.93	1.90	0.76	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	11.39	0.58	0.58	0.29	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	10.77	2.37	1.51	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	15.01	1.25	0.83	0.42	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	9.47	1.66	2.37	0.24	0.24
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	9.64	1.93	0.64	0.16	0.16
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	15.49	2.02	1.35	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	22.22	4.38	3.76	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	19.65	5.40	3.44	0.49	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	33.16	2.62	1.75	1.75	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	19.28	2.29	1.72	0.19	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	12.65	0.87	1.74	0.44	0.44
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	22.49	3.00	0.50	0.00	0.50
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	12.25	1.88	1.13	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	15.46	0.45	2.27	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	12.84	2.19	0.94	0.31	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	11.27	0.33	0.65	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	12.77	1.16	1.16	0.29	0.58
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	12.85	0.00	1.20	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	30.11	4.62	2.03	0.74	0.55
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	23.96	4.28	2.00	0.29	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	36.75	4.49	2.45	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	13.73	4.22	1.76	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	15.20	5.07	3.17	1.27	0.63
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	16.95	2.12	1.51	0.00	0.30
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	12.93	1.03	1.55	0.00	0.52
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	15.94	2.66	0.66	1.33	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	13.08	0.51	1.28	0.26	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	9.20	1.28	1.53	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	7.57	1.51	3.03	0.76	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	13.78	0.67	1.01	0.34	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	28.98	6.76	4.35	0.24	0.48
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	32.53	6.68	2.67	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	36.10	4.88	3.90	0.49	0.49
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	17.11	2.14	1.53	0.31	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	52.05	6.51	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	25.81	3.64	0.66	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	13.14	2.19	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	13.39	2.53	1.09	0.36	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	12.10	0.71	0.71	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	8.35	0.00	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	13.68	1.35	1.76	0.27	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	12.66	1.08	1.08	0.27	0.00
immature langerhans cells, donor1	11904-125F5	14.53	8.72	5.57	0.73	0.73
immature langerhans cells, donor2	11905-125F6	38.02	6.34	3.17	0.00	2.38
insula, adult, pool1	10039-101F3	35.01	8.14	4.83	0.95	0.38
keratoacanthoma cell line:HKA-1	10791-110H8	14.63	5.53	8.45	3.58	1.95
kidney, adult, pool1	10017-101C8	47.56	7.01	5.51	2.00	1.60
kidney, fetal, pool1	10045-101F9	49.94	5.02	2.33	0.64	0.85
large cell lung carcinoma cell line:IA-LM	10509-107D5	10.08	3.69	3.12	0.71	0.00
large cell lung carcinoma cell line:NCI-H460	10839-111E2	9.26	4.56	1.38	1.38	0.14
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	4.77	3.67	6.79	3.30	2.20
left atrium, adult, donor1	10079-102A7	30.51	7.08	1.63	0.54	0.00
left ventricle, adult, donor1	10078-102A6	44.50	3.54	5.06	0.00	0.51
leiomyoblastoma cell line:G-402	10721-110A1	7.11	7.39	0.82	1.09	0.00
leiomyoma cell line:10964C	10569-108B2	7.18	1.80	1.80	1.08	0.36
leiomyoma cell line:15242A	10570-108B3	4.35	0.00	0.54	0.00	0.00
leiomyoma cell line:15425	10571-108B4	5.58	0.97	0.49	0.00	0.00
leiomyosarcoma cell line:Hs 5.T	10722-110A2	6.35	0.00	6.35	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	9.41	2.09	2.09	0.00	0.00
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	10.63	4.37	2.72	0.47	0.12
liposarcoma cell line:KMLS-1	10782-110G8	5.31	1.25	1.09	0.16	0.16
liposarcoma cell line:SW 872	10726-110A6	9.50	3.29	0.49	1.22	0.73
liver, adult, pool1	10018-101C9	52.99	12.64	6.64	2.27	1.62
liver, fetal, pool1	10086-102B5	31.04	5.64	3.76	1.88	0.00
locus coeruleus - adult, donor10196	10182-103D2	26.69	3.35	2.92	0.58	0.58
locus coeruleus, adult, donor10252	10165-103B3	48.17	8.30	4.80	0.92	0.00
locus coeruleus, adult, donor10258	10375-105G6	34.70	7.90	5.08	1.13	0.85
locus coeruleus, newborn, donor10223	10362-105F2	36.17	4.21	2.10	0.84	0.00
lung adenocarcinoma cell line:A549	10499-107C4	10.10	5.54	2.21	1.66	0.14
lung adenocarcinoma cell line:PC-14	10408-106B3	16.55	2.76	1.38	2.07	0.69
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	15.82	7.65	5.27	1.98	0.66
lung, adult, pool1	10019-101D1	102.30	14.65	12.88	1.77	0.95
lung, fetal, donor1	10068-101I5	319.09	21.69	16.27	2.57	1.14
lung, right lower lobe, adult, donor1	10075-102A3	53.15	13.29	14.66	0.92	0.92
lymph node, adult, donor1	10077-102A5	17.51	5.68	2.37	0.47	0.47
lymphangiectasia cell line:DS-1	10727-110A7	26.08	3.95	3.29	0.44	0.00
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	29.58	16.30	13.43	2.41	0.75
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	12.74	11.89	7.65	4.25	2.55
mature adipocyte, donor1	12231-129F8	191.36	49.28	12.43	9.32	6.22
mature adipocyte, donor2	12232-129F9	161.66	33.62	12.04	5.81	4.57
mature adipocyte, donor3	12233-129G1	109.29	25.60	8.53	5.45	6.64
mature adipocyte, donor4	12234-129G2	167.14	57.38	18.69	10.00	8.69
maxillary sinus tumor cell line:HSQ-89	10414-106B9	28.59	5.96	7.15	1.67	0.95
medial frontal gyrus - adult, donor10196	10170-103B8	19.18	4.51	2.26	3.38	0.00
medial frontal gyrus, adult, donor10252	10150-102I6	42.11	4.78	2.39	0.55	0.37
medial frontal gyrus, adult, donor10258	10368-105F8	18.43	3.18	3.81	1.59	0.32
medial frontal gyrus, newborn, donor10223	10352-105E1	43.50	4.26	5.12	0.43	0.43
medial temporal gyrus - adult, donor10196	10183-103D3	25.48	5.40	3.04	0.34	0.17
medial temporal gyrus, adult, donor10252	10156-103A3	45.20	5.73	3.18	0.64	0.00
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	21.19	1.93	5.78	1.93	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	0.00	0.00	0.00	14.35	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	65.68	8.97	8.61	1.08	0.72
medulla oblongata - adult, donor10196	10174-103C3	22.71	3.89	3.89	1.30	0.65
medulla oblongata, adult, donor10252	10155-103A2	56.19	5.88	2.48	0.46	0.00
medulla oblongata, adult, pool1	10038-101F2	36.16	7.35	5.39	0.65	0.49
medulla oblongata, newborn, donor10223	10361-105F1	30.20	2.78	2.43	0.69	0.35
medulloblastoma cell line:D283 Med	10838-111E1	104.51	12.62	3.32	0.89	0.22
medulloblastoma cell line:ONS-76	10759-110E3	9.90	2.45	1.83	1.71	1.59
melanoma cell line:COLO 679	10514-107E1	12.94	6.90	1.15	1.87	0.57
melanoma cell line:G-361	10465-106H6	2.71	7.87	0.81	2.17	1.90
meningioma cell line:HKBMM	10691-109F7	8.68	5.07	0.54	0.54	0.18
merkel cell carcinoma cell line:MKL-1	10843-111E6	20.27	0.88	2.64	0.00	0.00
merkel cell carcinoma cell line:MS-1	10844-111E7	6.74	1.04	0.52	0.00	0.26
mesenchymal precursor cell - adipose, donor1	11747-123G1	4.30	1.53	0.00	0.46	0.00
mesenchymal precursor cell - adipose, donor2	11748-123G2	4.36	2.54	0.00	0.18	0.18
mesenchymal precursor cell - adipose, donor3	11749-123G3	9.94	3.31	0.41	0.00	0.00
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	6.74	3.51	1.12	0.56	0.00
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	6.35	4.62	1.35	0.96	0.39
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	15.96	4.16	2.08	1.39	0.69
mesenchymal precursor cell - cardiac, donor1	11752-123G6	6.01	0.51	0.69	0.17	0.00
mesenchymal precursor cell - cardiac, donor2	11753-123G7	7.13	5.87	1.27	1.04	0.12
mesenchymal precursor cell - cardiac, donor3	11754-123G8	3.45	2.25	0.40	0.13	0.00
mesenchymal precursor cell - cardiac, donor4	11755-123G9	4.59	2.70	0.41	0.27	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	5.55	1.42	0.43	0.43	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	6.26	0.99	0.33	0.00	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	4.70	1.66	0.42	0.42	0.14
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	4.19	4.54	1.05	0.70	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	3.88	2.04	1.02	0.00	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	5.03	1.80	0.36	0.00	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	3.93	0.83	0.21	0.21	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	7.07	0.23	0.00	0.46	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	7.97	0.42	0.84	0.00	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	4.18	1.79	0.60	0.45	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	6.48	1.75	1.05	0.18	0.26
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	4.79	2.21	0.74	1.10	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	3.15	1.14	1.14	0.29	0.00
mesenchymal stem cell line:Hu5/E18	10568-108B1	5.05	2.53	1.26	0.42	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	6.85	2.28	0.91	1.83	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	6.65	1.79	0.51	0.77	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	8.38	2.88	2.09	0.79	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	10.17	2.16	1.23	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	8.71	4.00	0.47	1.41	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	10.49	1.02	0.68	1.02	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	8.25	3.14	0.39	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	12.51	0.00	0.93	0.46	0.46
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	7.21	4.33	1.73	0.29	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	12.05	3.12	1.12	0.45	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	12.74	4.09	0.72	0.48	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	8.80	0.73	2.20	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	10.74	2.69	1.68	1.34	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	9.83	3.28	0.41	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	9.88	3.44	0.86	1.29	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	13.67	5.47	5.47	0.00	2.73
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	10.33	5.16	0.00	5.16	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	7.47	3.90	1.30	0.00	0.32
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	13.09	1.45	0.00	0.00	1.45
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	6.93	2.13	1.60	1.07	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	8.18	3.27	0.82	0.00	0.82
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	9.33	3.89	2.72	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	10.49	0.00	4.20	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	7.95	4.97	0.99	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	0.00	4.77	0.00	0.00	4.77
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	9.49	4.15	2.37	0.59	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	10.97	1.22	0.00	1.22	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	27.05	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	8.87	2.53	0.63	0.00	0.63
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	9.31	1.72	1.38	0.34	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	10.75	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	19.96	0.00	3.99	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	6.89	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	9.78	0.00	0.41	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	7.94	1.59	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	8.25	0.00	0.59	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	9.97	1.87	0.62	0.31	0.62
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	12.03	2.67	2.67	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	34.30	4.73	1.18	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	25.68	10.27	2.57	2.57	2.57
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	34.42	8.95	5.51	1.38	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	103.91	15.83	6.43	4.95	5.94
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	103.18	15.70	3.36	5.61	3.36
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	98.59	17.17	5.72	2.54	6.36
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	124.92	19.34	10.48	4.84	5.24
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	130.84	23.99	4.36	6.54	13.08
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	136.84	19.01	7.60	6.34	5.07
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	90.43	20.03	7.89	3.64	2.43
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	67.78	13.56	13.56	9.04	4.52
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	99.67	18.94	4.94	3.29	3.29
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	49.41	7.94	3.17	1.98	3.37
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	40.89	8.11	2.92	0.97	1.62
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	53.99	8.15	1.02	2.04	1.02
mesodermal tumor cell line:HIRS-BM	10696-109G3	10.06	6.19	0.77	0.00	0.00
mesothelioma cell line:ACC-MESO-1	10493-107B7	8.74	8.27	1.18	3.07	0.71
mesothelioma cell line:ACC-MESO-4	10494-107B8	14.13	0.46	0.46	0.46	0.00
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	4.27	0.00	0.00	4.27	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	6.17	1.23	0.31	0.62	0.41
mesothelioma cell line:Mero-25	10850-111F4	6.58	1.36	0.23	0.00	0.00
mesothelioma cell line:Mero-41	10851-111F5	12.96	2.93	0.24	0.73	0.00
mesothelioma cell line:Mero-48a	10852-111F6	7.97	1.99	0.00	0.66	0.44
mesothelioma cell line:Mero-82	10853-111F7	9.99	2.63	1.31	0.79	0.53
mesothelioma cell line:Mero-83	10854-111F8	7.49	2.21	1.02	0.34	0.34
mesothelioma cell line:Mero-84	10855-111F9	10.87	0.25	0.00	0.51	0.00
mesothelioma cell line:Mero-95	10856-111G1	12.84	2.07	0.83	0.41	0.00
mesothelioma cell line:NCI-H2052	10847-111F1	12.59	2.15	1.82	0.50	0.17
mesothelioma cell line:NCI-H226	10846-111E9	5.97	0.72	0.18	0.54	0.18
mesothelioma cell line:NCI-H2452	10848-111F2	8.20	3.93	0.17	0.17	0.17
mesothelioma cell line:NCI-H28	10845-111E8	35.12	2.54	1.27	0.76	0.25
mesothelioma cell line:No36	10857-111G2	12.40	1.63	0.65	0.33	0.00
mesothelioma cell line:ONE58	10858-111G3	14.09	2.98	1.90	0.27	0.00
migratory langerhans cells, donor1	11901-125F2	5.76	3.65	0.38	0.38	0.19
migratory langerhans cells, donor2	11902-125F3	9.04	4.03	0.37	0.12	0.00
migratory langerhans cells, donor3	11903-125F4	11.67	7.18	0.18	0.36	0.00
mixed mullerian tumor cell line:HTMMT	10689-109F5	9.47	4.90	0.33	0.98	1.63
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	5.93	1.48	0.00	0.21	0.21
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	8.75	5.53	5.53	0.23	0.46
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	3.81	7.23	4.38	1.33	0.38
myelodysplastic syndrome cell line:SKM-1	10772-110F7	26.79	21.62	4.07	2.22	0.00
myeloma cell line:PCM6	10474-106I6	8.10	11.07	10.08	2.17	0.00
myxofibrosarcoma cell line:MFH-ino	10600-108E6	7.10	2.03	0.51	0.51	0.00
myxofibrosarcoma cell line:NMFH-1	10684-109E9	10.00	5.10	2.16	1.37	0.78
nasal epithelial cells, donor1, tech_rep1	12226-129F3	15.93	1.56	3.57	0.45	0.33
nasal epithelial cells, donor1, tech_rep2	12226-129F3	15.59	1.99	2.06	0.37	0.07
nasal epithelial cells, donor2	12227-129F4	11.59	6.62	2.21	3.31	1.66
neuroblastoma cell line:CHP-134	10508-107D4	9.89	0.69	0.23	0.23	0.23
neuroblastoma cell line:NB-1	10539-107G8	35.92	12.72	7.67	1.12	0.19
neuroblastoma cell line:NBsusSR	10607-108F4	11.81	4.01	0.63	0.21	0.00
neuroblastoma cell line:NH-12	10555-107I6	10.81	1.68	0.56	0.56	0.19
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	13.52	1.66	0.00	0.00	0.00
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	5.54	1.58	0.63	0.00	0.16
neuroectodermal tumor cell line:TASK1	10774-110F9	8.45	2.01	0.40	0.81	0.20
neuroepithelioma cell line:SK-N-MC	10728-110A8	6.36	1.27	0.64	0.00	0.00
neurofibroma cell line:Hs 53.T	10729-110A9	6.12	2.93	1.86	0.27	0.00
neutrophil PMN, donor1	12133-128D9	1442.86	178.50	104.12	0.00	14.87
neutrophil PMN, donor2	12137-128E4	292.17	66.40	53.12	0.00	0.00
neutrophil PMN, donor3	12141-128E8	227.30	18.94	28.41	9.47	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	24.52	32.13	2.88	4.74	2.37
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	33.62	10.41	8.01	0.00	0.00
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	8.34	4.17	1.92	0.32	0.64
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	9.99	1.84	1.31	0.79	0.26
nucleus accumbens, adult, pool1	10037-101F1	34.87	9.47	6.84	0.56	0.47
occipital cortex - adult, donor10196	10172-103C1	24.72	2.06	0.00	0.00	0.00
occipital cortex, adult, donor10252	10163-103B1	62.80	6.17	3.76	0.81	0.27
occipital cortex, newborn, donor10223	10355-105E4	76.06	8.01	9.10	1.46	0.73
occipital lobe, adult, donor1	10076-102A4	25.19	6.56	7.35	0.79	0.26
occipital lobe, fetal, donor1	10073-102A1	21.88	0.43	1.29	0.00	0.43
occipital pole, adult, pool1	10036-101E9	19.79	4.57	3.15	0.63	0.63
olfactory region, adult	10195-103E6	30.76	6.88	4.20	0.96	0.57
optic nerve, donor1	10277-104E7	46.02	16.01	14.01	4.00	0.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	28.59	5.58	3.53	4.21	6.61
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	13.05	4.67	2.47	3.43	2.61
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	12.36	4.74	5.93	4.57	4.40
oral squamous cell carcinoma cell line:SAS	10544-107H4	4.27	5.08	4.97	1.62	0.92
osteoclastoma cell line:Hs 706.T	10704-109H2	8.53	4.70	0.29	0.59	0.29
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	7.47	12.15	1.87	3.74	1.87
osteosarcoma cell line:HS-Os-1	10558-107I9	18.87	16.33	2.33	1.70	0.85
ovary, adult, pool1	10020-101D2	26.38	3.84	2.88	0.79	0.00
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	5.87	4.03	1.28	0.55	0.37
pancreas, adult, donor1	10049-101G4	47.03	4.70	17.87	2.82	0.00
pancreatic carcinoma cell line:NOR-P1	10698-109G5	26.28	0.84	3.63	1.68	1.68
papillary adenocarcinoma cell line:8505C	10437-106E5	11.07	1.87	1.70	1.19	0.68
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	16.06	7.62	4.31	2.48	0.50
paracentral gyrus, adult, pool1	10035-101E8	31.39	6.86	5.58	0.27	0.27
parietal cortex, adult, donor10258	10373-105G4	33.03	2.94	5.87	0.73	0.73
parietal lobe - adult, donor10196	10171-103B9	29.15	2.82	3.76	2.82	0.00
parietal lobe, adult, donor10252	10157-103A4	48.17	5.42	3.42	0.86	0.00
parietal lobe, adult, pool1	10034-101E7	35.25	7.05	5.20	0.79	0.44
parietal lobe, fetal, donor1	10072-101I9	24.25	0.97	1.94	0.00	0.00
parietal lobe, newborn, donor10223	10356-105E5	70.66	7.48	5.23	0.00	0.00
parotid gland, adult	10199-103F1	46.87	4.93	7.40	0.00	0.62
penis, adult	10200-103F2	67.68	5.37	5.91	1.61	0.54
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	10.78	1.12	0.19	0.56	0.19
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	10.20	7.14	5.83	1.75	2.19
pineal gland - adult, donor10196	10179-103C8	20.64	5.16	3.23	1.29	0.00
pineal gland, adult, donor10252	10160-103A7	33.16	7.70	3.55	0.00	0.00
pineal gland, adult, donor10258	10377-105G8	21.32	1.88	3.76	0.00	0.00
pituitary gland - adult, donor10196	10180-103C9	26.31	3.04	3.04	1.01	0.00
pituitary gland, adult, donor10252	10162-103A9	68.80	4.69	11.47	0.52	0.00
pituitary gland, adult, donor10258	10378-105G9	48.52	0.85	0.85	0.00	0.00
placenta, adult, pool1	10021-101D3	34.08	2.90	1.29	0.32	0.11
plasma cell leukemia cell line:ARH-77	10840-111E3	10.86	11.79	2.12	0.79	0.26
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	10.27	3.42	0.78	1.25	0.16
pons, adult, pool1	10033-101E6	34.86	5.94	5.42	0.95	0.77
postcentral gyrus, adult, pool1	10032-101E5	24.58	5.93	2.96	0.70	0.35
promyelocytes/myelocytes PMC, donor1	12132-128D8	83.66	35.55	37.65	0.00	4.18
promyelocytes/myelocytes PMC, donor2	12136-128E3	44.06	11.02	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	11.74	0.00	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	15.44	11.36	3.79	2.18	0.58
prostate cancer cell line:PC-3	10439-106E7	41.75	7.08	8.17	1.63	0.73
prostate, adult, pool1	10022-101D4	69.29	9.61	10.25	1.18	0.73
putamen, adult, donor10196	10176-103C5	34.70	10.15	5.90	1.42	0.47
putamen, adult, donor10252	10152-102I8	52.94	7.84	11.76	1.96	0.00
putamen, adult, donor10258, tech_rep1	10372-105G3	38.25	3.28	5.46	0.00	0.00
putamen, adult, donor10258, tech_rep2	10372-105G3	43.01	8.21	8.21	0.97	0.97
putamen, newborn, donor10223	10365-105F5	25.49	1.50	3.00	0.75	0.75
rectal cancer cell line:TT1TKB	10469-106I1	15.71	4.95	11.64	1.16	0.58
rectum, fetal, donor1	10067-101I4	44.51	2.78	2.78	1.39	0.00
renal cell carcinoma cell line:OS-RC-2	10411-106B6	24.38	5.72	1.91	1.91	0.42
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	14.50	10.36	0.41	0.00	0.41
retina, adult, pool1	10030-101E3	48.21	6.06	5.67	1.39	0.50
retinoblastoma cell line:Y79	10475-106I7	16.11	4.16	1.82	0.52	0.00
rhabdomyosarcoma cell line:KYM-1	10787-110H4	11.43	4.30	0.37	1.35	0.61
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	5.62	1.69	0.28	0.28	0.28
sacrococcigeal teratoma cell line:HTST	10695-109G2	28.80	7.58	4.55	3.03	0.76
salivary acinar cells, donor1	11771-123I7	8.25	3.56	0.97	0.97	1.13
salivary acinar cells, donor2	11772-123I8	12.12	3.99	3.30	1.38	0.55
salivary acinar cells, donor3	11773-123I9	24.50	1.99	3.31	1.99	0.66
salivary gland, adult, pool1	10093-102C3	62.34	1.72	16.01	0.00	1.72
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	11.55	4.97	2.78	0.34	0.00
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	9.40	4.47	3.29	0.82	0.12
seminal vesicle, adult	10201-103F3	48.67	3.17	7.94	2.12	0.53
serous adenocarcinoma cell line:JHOS-2	10639-108I9	12.63	2.92	2.19	0.49	1.21
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	7.80	3.02	0.75	0.50	0.25
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	6.02	1.00	2.01	0.00	0.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	19.61	2.69	1.34	1.34	0.67
signet ring carcinoma cell line:Kato III	10436-106E4	23.98	4.42	5.86	1.33	0.33
signet ring carcinoma cell line:NUGC-4	10483-107A6	17.68	6.19	4.39	0.26	0.26
skeletal muscle - soleus muscle, donor1	10282-104F3	49.65	11.35	6.38	0.00	1.42
skeletal muscle, adult, pool1	10023-101D5	40.66	8.76	7.80	0.60	0.12
skeletal muscle, fetal, donor1	10066-101I3	25.13	1.01	0.00	2.01	0.00
skin, adult, donor1	10074-102A2	33.93	6.79	0.00	0.00	0.00
skin, fetal, donor1	10065-101I2	39.14	7.57	3.79	0.63	0.63
small cell cervical cancer cell line:HCSC-1	10800-110I8	12.01	2.67	0.67	0.67	0.00
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	11.98	0.00	0.95	0.63	0.32
small cell lung carcinoma cell line:DMS 144	10841-111E4	24.86	1.93	0.39	0.00	0.00
small cell lung carcinoma cell line:LK-2	10541-107H1	9.56	2.80	2.80	0.16	0.33
small cell lung carcinoma cell line:NCI-H82	10842-111E5	40.05	2.73	1.29	0.16	0.00
small cell lung carcinoma cell line:WA-hT	10562-108A4	19.39	1.74	5.01	0.00	0.22
small intestine, adult, pool1	10024-101D6	78.35	8.72	11.82	1.07	0.36
small intestine, fetal, donor1	10064-101I1	31.45	2.21	5.90	0.74	0.00
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	57.44	4.10	4.62	1.54	0.00
smooth muscle, adult, pool1	10048-101G3	52.98	9.05	9.56	0.00	0.00
somatostatinoma cell line:QGP-1	10781-110G7	8.84	1.88	9.92	0.27	0.27
spinal cord - adult, donor10196	10181-103D1	28.91	4.82	4.13	0.23	0.23
spinal cord, adult, donor10252	10159-103A6	48.10	4.73	3.55	1.18	0.00
spinal cord, adult, donor10258	10369-105F9	39.43	2.08	4.84	0.00	0.00
spinal cord, fetal, donor1	10056-101H2	37.20	9.15	3.66	1.22	1.22
spinal cord, newborn, donor10223	10359-105E8	38.57	5.51	2.30	0.00	0.00
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	6.57	2.99	1.05	1.19	0.00
spleen, adult, pool1	10025-101D7	59.03	11.78	4.52	0.99	0.33
spleen, fetal, pool1	10044-101F8	65.23	9.38	3.10	0.79	0.40
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	11.39	6.73	0.93	0.41	0.00
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	12.91	1.90	2.66	0.19	0.38
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	31.45	2.45	1.75	2.45	0.70
squamous cell carcinoma cell line:T3M-5	10616-108G4	6.65	2.35	3.52	0.00	0.78
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	17.33	2.93	12.72	0.68	0.11
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	25.84	5.08	1.69	0.85	1.27
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	11.00	10.15	3.38	5.92	1.27
stomach, fetal, donor1	10062-101H8	30.97	6.41	24.56	0.00	2.14
submaxillary gland, adult	10202-103F4	51.27	5.70	14.81	0.57	0.57
substantia nigra - adult, donor10196	10178-103C7	0.00	54.27	0.00	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	72.28	10.80	4.15	0.62	0.00
substantia nigra, adult, donor10258	10371-105G2	42.93	7.24	5.69	0.52	0.52
substantia nigra, newborn, donor10223	10358-105E7	50.17	4.95	3.53	0.71	0.00
synovial sarcoma cell line:HS-SY-II	10441-106E9	21.32	2.98	0.46	0.00	0.69
temporal lobe, adult, pool1	10031-101E4	22.63	4.41	2.20	1.19	0.25
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	37.75	2.14	1.42	0.00	0.00
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	29.45	2.20	0.44	0.00	0.00
tenocyte, donor1	11763-123H8	12.22	2.79	0.35	0.35	0.00
tenocyte, donor2	11765-123I1	15.64	1.53	2.67	0.76	0.00
tenocyte, donor3	11768-123I4	12.60	2.22	1.85	1.11	0.00
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	21.92	2.55	1.70	0.34	0.51
teratocarcinoma cell line:NCR-G1	10798-110I6	16.65	3.70	1.08	0.00	0.46
teratocarcinoma cell line:PA-1	10807-111A6	12.24	2.48	1.70	0.62	0.31
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	20.57	2.41	4.70	0.51	0.63
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	29.50	1.13	2.27	0.00	0.38
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	45.59	2.62	8.07	0.98	1.31
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	26.38	0.65	1.63	0.00	0.33
testis, adult, pool1	10026-101D8	31.89	4.40	5.48	0.86	0.32
testis, adult, pool2	10096-102C6	28.42	5.41	4.96	0.00	0.00
thalamus - adult, donor10196	10168-103B6	35.33	6.62	6.62	2.21	0.00
thalamus, adult, donor10252	10154-103A1	77.83	10.00	5.63	0.94	0.00
thalamus, adult, donor10258, tech_rep1	10370-105G1	56.97	9.24	9.24	0.00	0.00
thalamus, adult, donor10258, tech_rep2	10370-105G1	18.61	5.27	3.46	0.66	0.49
thalamus, newborn, donor10223	10366-105F6	23.59	2.88	0.58	0.00	1.15
throat, adult	10209-103G2	60.67	8.99	6.49	1.00	0.25
throat, fetal, donor1	10061-101H7	39.00	6.09	9.14	2.13	0.30
thymic carcinoma cell line:Ty-82	10803-111A2	18.28	0.99	0.20	0.00	0.00
thymus, adult, pool1	10027-101D9	75.75	20.28	11.13	1.79	0.40
thymus, fetal, pool1	10043-101F7	86.86	17.25	6.23	1.35	0.10
thyroid carcinoma cell line:KHM-5M	10776-110G2	9.31	6.12	0.80	1.46	0.13
thyroid carcinoma cell line:TCO-1	10783-110G9	22.07	8.52	4.33	1.26	1.40
thyroid, adult, pool1	10028-101E1	58.60	9.89	18.94	2.80	0.84
thyroid, fetal, donor1	10060-101H6	41.40	5.01	17.93	1.58	0.79
tongue epidermis (fungiform papillae), donor1	10288-104F9	46.19	12.32	12.32	6.16	0.00
tongue, adult	10203-103F5	59.31	7.91	6.05	0.70	0.47
tongue, fetal, donor1	10059-101H5	42.17	5.12	2.76	0.00	0.00
tonsil, adult, pool1	10047-101G2	39.37	12.52	10.32	0.90	0.30
trachea, adult, pool1	10029-101E2	44.25	5.32	8.10	1.23	0.33
trachea, fetal, donor1	10058-101H4	42.32	3.85	4.62	0.00	0.00
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	8.15	3.90	2.83	1.77	0.00
transitional-cell carcinoma cell line:5637	10418-106C4	10.74	3.55	1.01	1.01	0.30
transitional-cell carcinoma cell line:JMSU1	10492-107B6	9.87	4.86	1.88	1.10	0.31
tridermal teratoma cell line:HGRT	10694-109G1	13.32	7.61	5.71	1.90	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	5.67	2.62	1.52	0.51	0.08
umbilical cord, fetal, donor1	10057-101H3	18.78	2.09	4.17	2.09	0.00
uterus, adult, pool1	10100-102D1	67.40	6.14	5.46	0.51	0.00
uterus, fetal, donor1	10055-101H1	28.16	3.07	2.05	0.51	0.00
vagina, adult	10204-103F6	82.71	7.11	5.82	2.58	0.00
vein, adult	10191-103E2	67.73	10.08	5.48	0.88	0.44
xeroderma pigentosum b cell line:XPL 17	10563-108A5	7.21	4.81	0.80	0.80	0.00